{"study_id": 13057, "supplement_id": 1111, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to evaluate the usage and clinical impact of erythropoiesis-stimulating agents (ESAs) in patients with lower-risk myelodysplastic syndrome (MDS), focusing on survival benefits and transfusion needs.", "results_summary": "ESA treatment was associated with a nonsignificant survival benefit and significantly delayed the onset of regular transfusion needs, particularly in patients without prior transfusions. Responding patients had a lower risk of death, but no significant effect was observed on progression to acute myeloid leukemia.", "population_specificity": "Newly diagnosed patients with lower-risk MDS from 17 European countries.", "effective_dosage": "Not specified", "study_duration": "Median duration of 27.5 months (range 0-77 months)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:49:53.775180+00:00"}
{"study_id": 13058, "supplement_id": 1111, "safety_score": "Not Assessed", "efficacy_score": 30, "quality_score": 75, "study_goal": "The researchers aimed to determine if intravenous vitamin B6 supplementation could improve ESA resistance and bone turnover markers in hemodialysis patients with high ESA resistance.", "results_summary": "The study found that vitamin B6 worsened ESA response (increased resistance index) and may have blunted bone response to parathyroid hormone, particularly in patients without baseline B6 deficiency. There was a trend toward increased serum erythropoietin concentrations but no significant impact on parathyroid hormone levels.", "population_specificity": "Fifty-six maintenance hemodialysis patients with high resistance to erythropoiesis-stimulating agents (ESA).", "effective_dosage": "60 mg of intravenous pyridoxal 5'-phosphate after each thrice-weekly hemodialysis session.", "study_duration": "6 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:49:53.799507+00:00"}
{"study_id": 187859, "supplement_id": 1111, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers explored the relationship between gut dysbiosis in CKD and renal anemia, and how improving gut health could enhance the response to Erythropoiesis-Stimulating Agents (ESAs) in ESA-resistant patients.", "results_summary": "The study suggests that addressing gut dysbiosis in CKD patients can improve anemia control and enhance ESA response, particularly in ESA-resistant cases, by promoting beneficial microbiota and reducing uremic toxins and inflammation.", "population_specificity": "Chronic kidney disease (CKD) patients, particularly those with anemia and ESA-resistant cases.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:49:54.109699+00:00"}
{"study_id": 187862, "supplement_id": 1111, "safety_score": "Not Assessed", "efficacy_score": 50, "quality_score": 70, "study_goal": "The researchers aimed to compare the effectiveness of erythropoiesis-stimulating agents and other therapies for managing perioperative anemia.", "results_summary": "The study found conflicting evidence on the optimal treatment for perioperative anemia, noting differences among international guidelines and the need for further research. Erythropoiesis-stimulating agents were discussed as a potential therapy, but no definitive conclusions were drawn about their superiority.", "population_specificity": "Patients with perioperative anemia.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:49:56.739819+00:00"}
{"study_id": 187860, "supplement_id": 1111, "safety_score": "70", "efficacy_score": 80, "quality_score": 85, "study_goal": "The researchers aimed to compare the effectiveness and safety of HIF-PHIs versus Erythropoiesis-Stimulating Agents (ESAs) for treating anemia in chronic kidney disease (CKD).", "results_summary": "HIF-PHIs were found to be non-inferior to ESAs in maintaining or improving hemoglobin levels, but concerns about adverse events (cardiovascular outcomes, thrombosis, tumor progression) and lack of long-term safety data limit their widespread approval. ESAs remain a standard treatment, but HIF-PHIs may be considered for specific patients under caution.", "population_specificity": "Patients with chronic kidney disease (CKD).", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:49:57.414954+00:00"}
{"study_id": 187861, "supplement_id": 1111, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to evaluate the validity of current iron deficiency criteria in heart failure patients and assess the efficacy of intravenous iron as an adjunct to erythropoiesis-stimulating agents.", "results_summary": "The study found that a TSAT <20% reliably predicted the benefit of intravenous iron in reducing major heart failure events, while serum ferritin levels <100 \u03bcg/L alone did not show significant benefits. The risk reduction was proportional to the severity of hypoferraemia.", "population_specificity": "Patients with heart failure and iron deficiency (defined by TSAT <20% and serum ferritin <400 \u03bcg/L).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:49:57.658102+00:00"}
{"study_id": 187863, "supplement_id": 1111, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to review current treatment standards and recent developments in managing anemia in chronic kidney disease (CKD), focusing on the role of Erythropoiesis-Stimulating Agents (ESAs) and iron supplementation.", "results_summary": "ESAs, combined with iron supplementation, effectively manage anemia in CKD by addressing erythropoietin deficiency and iron regulation. Newer hypoxia-inducible factor-prolyl hydroxylase inhibitors show high efficacy but raise safety concerns for long-term use.", "population_specificity": "Patients with chronic kidney disease (CKD) and associated anemia.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:49:58.904516+00:00"}
{"study_id": 187864, "supplement_id": 1111, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to evaluate the impact and management of erythropoiesis-stimulating agents (ESAs) and hypoxia-inducible factor stabilizers (HIF) in chronic kidney disease (CKD) patients, focusing on individualized hemoglobin objectives, resistance to ESA, and cardiovascular safety.", "results_summary": "The study reached consensus on 16 statements related to ESAs and HIF stabilizers, including individualized hemoglobin targets and management of ESA resistance. However, it highlighted the need for further clinical studies on the effects of anemia treatment with various ESAs on quality of life, CKD progression, and cardiovascular events.", "population_specificity": "Chronic kidney disease (CKD) patients with anemia.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:49:59.722900+00:00"}
{"study_id": 187865, "supplement_id": 1111, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to determine how erythropoiesis-stimulating agents and hemoglobin-based red blood cell transfusion thresholds affect preterm infant neurodevelopment.", "results_summary": "The study highlighted negative effects of iron deficiency and anemia on infant brain development but did not provide conclusive results on the efficacy of erythropoiesis-stimulating agents. It suggested a need for biomarkers to evaluate treatment options and brain response.", "population_specificity": "Preterm infants", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:50:01.803636+00:00"}
{"study_id": 187866, "supplement_id": 1111, "safety_score": "Not Assessed", "efficacy_score": 80, "quality_score": 70, "study_goal": "The researchers aimed to evaluate the efficacy and emerging alternatives (PH-HIF inhibitors) for treating renal anemia, particularly in patients resistant to erythropoiesis-stimulating agents.", "results_summary": "The study found that PH-HIF inhibitors are effective in maintaining target hemoglobin levels, offering a new oral treatment option for renal anemia, though long-term safety remains unclear. Erythropoiesis-stimulating agents remain a standard treatment, but resistance in some patients highlights the need for alternatives.", "population_specificity": "Patients with kidney disease-associated anemia, particularly those resistant to erythropoiesis-stimulating agents.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:50:02.302936+00:00"}
{"study_id": 187870, "supplement_id": 1111, "safety_score": "30", "efficacy_score": 50, "quality_score": 60, "study_goal": "The researchers aimed to investigate the occurrence of adverse events associated with erythropoiesis-stimulating agents (ESAs) and iron therapy in preoperative anemia treatment.", "results_summary": "The study found very low certainty evidence regarding the safety of ESA and/or iron therapy, with most adverse event data focusing on mortality, thromboembolic, infectious, cardiovascular, and gastrointestinal events. The high risk of bias and limitations in study design, data collection, and reporting contributed to the uncertainty.", "population_specificity": "Adult elective surgery patients with preoperative anemia.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:50:05.785356+00:00"}
{"study_id": 187869, "supplement_id": 1111, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to evaluate the effectiveness of erythropoiesis-stimulating agents (ESAs) combined with intravenous iron in reducing the need for red blood cell transfusions and improving outcomes in anemic patients scheduled for cardiac surgery.", "results_summary": "The study found that combined therapy with ESAs and intravenous iron may effectively reduce the need for red blood cell transfusions, even when administered shortly before surgery, though the impact on morbidity and mortality remains unclear.", "population_specificity": "Anemic patients scheduled for elective cardiac surgery.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:50:05.956485+00:00"}
{"study_id": 187868, "supplement_id": 1111, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 88, "study_goal": "The researchers aimed to evaluate methods for assessing hyporesponsiveness to erythropoiesis-stimulating agents (ESAs) in non-dialysis-dependent chronic kidney disease (ND-CKD) patients and its association with renal and cardiovascular outcomes.", "results_summary": "The study found that hyporesponsiveness to ESA, measured as the dose of darbepoetin alfa (DA) divided by hemoglobin (Hb) level at 12 weeks, was significantly associated with increased risks of renal dysfunction (HR 1.449) and cardiovascular events (HR 1.719), with an optimal cut-off value of 5.2.", "population_specificity": "1,980 adult patients with non-dialysis-dependent chronic kidney disease (ND-CKD) and renal anemia.", "effective_dosage": "Not specified (administered according to JSDT guidelines).", "study_duration": "Mean follow-up period of 96 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:50:07.270459+00:00"}
{"study_id": 187871, "supplement_id": 1111, "safety_score": "60", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the safety and efficacy of erythropoiesis-stimulating agents (ESAs) for treating anemia in chronic kidney disease (CKD) and compare them with novel hypoxia-inducible factor-prolyl hydroxylase inhibitors (HIF-PHIs).", "results_summary": "ESAs are highly efficacious for treating anemia in CKD but are associated with increased cardiovascular risks at high hemoglobin targets. HIF-PHIs show noninferior efficacy to ESAs but have mixed safety profiles, with some compounds linked to thromboembolic events.", "population_specificity": "Patients with chronic kidney disease (CKD), including both dialysis-dependent and non-dialysis-dependent individuals.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:50:08.293465+00:00"}
{"study_id": 187872, "supplement_id": 1111, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 85, "study_goal": "The researchers aimed to assess the benefits and potential harms of hypoxia-inducible factor (HIF) stabilisers compared to erythropoiesis-stimulating agents (ESAs), placebo, or standard care for managing anaemia in chronic kidney disease (CKD) patients.", "results_summary": "HIF stabilisers probably reduced the need for blood transfusions and increased the proportion of patients reaching target haemoglobin levels compared to placebo, but their effects on cardiovascular death, nonfatal myocardial infarction, and fatigue were uncertain. Compared to ESAs, HIF stabilisers showed little to no difference in cardiovascular outcomes but may reduce transfusion requirements.", "population_specificity": "Adults with chronic kidney disease (30,994 participants across 51 studies).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:50:09.043436+00:00"}
{"study_id": 187867, "supplement_id": 1111, "safety_score": "80", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to compare two fixed-dose intravenous iron protocols (100 mg vs. 200 mg monthly) to reduce erythropoiesis-stimulating agents (ESA) usage in hemodialysis patients.", "results_summary": "The 200-mg IV iron group showed a significant reduction in ESA doses compared to the 100-mg group, with lower rates of iron deficiency anemia but a higher iron withholding rate. Safety outcomes, including mortality and adverse events, were similar between groups.", "population_specificity": "Hemodialysis patients with ferritin levels between 200\u2013700 ng/dl and transferrin saturation values between 20\u201340%.", "effective_dosage": "100 mg or 200 mg of IV iron administered monthly.", "study_duration": "12 months.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:50:09.428189+00:00"}
{"study_id": 187873, "supplement_id": 1111, "safety_score": "80", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to assess the efficacy of sucrosomial iron in combination with ESAs for improving hematological response in cancer patients with chemotherapy-induced anemia.", "results_summary": "The study found a statistically significant improvement in complete hematological response with sucrosomial iron supplementation (52% vs. 31% in the control group). No safety concerns or differences in transfusion need were observed.", "population_specificity": "Cancer patients with chemotherapy-induced anemia.", "effective_dosage": "30 mg daily of oral sucrosomial iron.", "study_duration": "12 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:50:09.860958+00:00"}
{"study_id": 187875, "supplement_id": 1111, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to assess the prevalence, associated factors, and treatment status of anemia and ESA hyporesponsiveness in non-dialysis-dependent CKD patients.", "results_summary": "The study found that 23.5% of patients had anemia, with ESA hyporesponsiveness increasing with CKD stage progression. Many patients did not receive adequate iron supplementation despite iron deficiency, suggesting a need for better interventions.", "population_specificity": "4,460 non-dialysis-dependent chronic kidney disease (CKD) patients in Japan.", "effective_dosage": "Not specified (measured by erythropoietin-resistance index: erythropoietin dose per week divided by body weight and Hb level).", "study_duration": "Not specified (cross-sectional study).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:50:12.135998+00:00"}
{"study_id": 187877, "supplement_id": 1111, "safety_score": "60", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the pharmacology of roxadustat, a HIF-PHI, as an alternative to Erythropoiesis-Stimulating Agents (ESAs) for treating renal anemia in CKD patients, focusing on its safety and efficacy.", "results_summary": "Roxadustat effectively increased and maintained hemoglobin levels in CKD patients, improved iron metabolism, and reduced IV iron requirements, but was associated with frequent thromboembolic events. It is considered a promising alternative, especially for ESA-hyporesponsive patients, though proper patient selection and use are crucial.", "population_specificity": "Chronic kidney disease (CKD) patients, both nondialysis-dependent and dialysis-dependent.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:50:15.724105+00:00"}
{"study_id": 187878, "supplement_id": 1111, "safety_score": "70", "efficacy_score": 80, "quality_score": 85, "study_goal": "The researchers aimed to compare the mechanisms, clinical applications, and safety profiles of HIF-PHIs and ESAs in treating renal anemia, while summarizing recent clinical trials.", "results_summary": "The study found that ESAs are effective for renal anemia with relatively few adverse effects, but higher doses correlate with increased mortality in hemodialysis patients. HIF-PHIs show promise in reducing hepcidin levels, improving iron metabolism, and lowering inflammation, though long-term safety data are lacking.", "population_specificity": "Patients with chronic kidney disease (CKD) and end-stage renal disease, including dialysis-dependent and non-dialysis patients.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:50:15.874263+00:00"}
{"study_id": 187876, "supplement_id": 1111, "safety_score": "60", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the effectiveness and safety of Erythropoiesis-Stimulating Agents (ESAs) in treating anemia in chronic kidney disease (CKD) patients, comparing them with emerging alternatives like HIF-PHIs.", "results_summary": "ESAs, combined with iron supplementation, effectively reduce transfusion dependence and achieve optimal hemoglobin levels in CKD patients, but there is no evidence they reduce cardiovascular risks. Intravenous iron supplementation increases risks of allergic reactions, infections, and cardiovascular events. HIF-PHIs show comparable efficacy to ESAs in trials.", "population_specificity": "Chronic kidney disease (CKD) patients, both dialysis and non-dialysis.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:50:16.006690+00:00"}
{"study_id": 187879, "supplement_id": 1111, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to evaluate the effectiveness and safety of oral iron polysaccharide complex compared to intravenous iron sucrose in treating anemia in maintenance hemodialysis patients.", "results_summary": "The study compares oral iron polysaccharide complex with intravenous iron sucrose, focusing on efficacy and safety endpoints like TSAT, Hb, SF, and quality of life, but final results are not yet reported in the abstract.", "population_specificity": "Maintenance hemodialysis patients aged 18-75 with specific Hb, TSAT, and SF levels, excluding those with acute/chronic bleeding, low serum albumin, high HsCRP, or severe hyperparathyroidism.", "effective_dosage": "Experimental group: iron polysaccharide complex (2 capsules, bid); control group: iron sucrose (100mg, every 2 weeks).", "study_duration": "24 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:50:18.470326+00:00"}
{"study_id": 187883, "supplement_id": 1111, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to compare the efficacy and cost-effectiveness of intravenous ferric carboxymaltose (FCM) versus oral ferrous sulfate for treating iron-deficiency anemia in non-dialysis-dependent chronic kidney disease (NDD-CKD) patients, with a focus on erythropoiesis-stimulating agents (ESAs) usage.", "results_summary": "The study found that FCM significantly improved hemoglobin, ferritin, and transferrin saturation levels compared to ferrous sulfate at 18 months, while also reducing ESAs dosage and treatment costs.", "population_specificity": "349 NDD-CKD patients attending an outpatient clinic.", "effective_dosage": "Not specified", "study_duration": "18 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:50:18.473287+00:00"}
{"study_id": 187882, "supplement_id": 1111, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to determine whether correcting anemia (using a high hemoglobin target) and vitamin D supplementation could slow the decline in eGFR among kidney transplant recipients.", "results_summary": "The study found that a high hemoglobin target (>12.5 g/dl) resulted in a smaller 2-year decline in eGFR (-1.6 \u00b1 4.5 ml/min/1.73 m\u00b2) compared to a low hemoglobin target (-4.0 \u00b1 6.9 ml/min/1.73 m\u00b2), suggesting potential benefits of anemia correction in this population.", "population_specificity": "Kidney transplant recipients (KTRs) with anemia and >1-year post-transplantation history across 23 facilities in Japan.", "effective_dosage": "Hemoglobin targets (>12.5 g/dl vs. <10.5 g/dl); cholecalciferol 1000 IU/day (for vitamin D arm).", "study_duration": "2 years", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:50:20.532197+00:00"}
{"study_id": 187884, "supplement_id": 1111, "safety_score": "75", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the safety, efficacy, and advancements in erythropoiesis-stimulating agents and novel iron replacement therapies for managing iron deficiency anemia in chronic kidney disease patients.", "results_summary": "The study found that novel iron replacement therapies, such as oral ferric citrate and new-generation IV iron preparations, are effective and safe, reducing the required dose of erythropoiesis-stimulating agents and improving hemoglobin levels. These therapies also offer additional benefits like reducing fibroblast growth factor 23 levels and activating 1,25 dihydroxyvitamin D.", "population_specificity": "Patients with chronic kidney disease, including those undergoing hemodialysis.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:50:21.127700+00:00"}
{"study_id": 187886, "supplement_id": 1111, "safety_score": "60", "efficacy_score": 70, "quality_score": 75, "study_goal": "The researchers aimed to investigate current treatment practices for anemia in CKD patients, including the use of Erythropoiesis-Stimulating Agents (ESAs), and explore potential alternatives like HIF-PHIs.", "results_summary": "The study found that while ESAs are traditionally used for anemia in CKD, they are associated with adverse cardiovascular events and hypo-responsiveness, prompting the exploration of HIF-PHIs as alternatives. HIF-PHIs show promise in stimulating erythropoiesis and regulating iron metabolism.", "population_specificity": "Patients with chronic kidney disease (CKD).", "effective_dosage": "Not Assessed", "study_duration": "Not Assessed", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:50:24.358303+00:00"}
{"study_id": 187887, "supplement_id": 1111, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to review the effectiveness and safety of intravenous iron therapy, often used alongside erythropoiesis-stimulating agents, in managing iron deficiency in heart failure and chronic kidney disease (CKD).", "results_summary": "Intravenous iron therapy improved heart failure symptoms and physical function in patients with reduced ejection fraction and iron deficiency, regardless of anemia, and may reduce hospitalizations and cardiovascular mortality. In CKD, sustained intravenous iron therapy improved outcomes without apparent infectious complications.", "population_specificity": "Patients with heart failure (particularly reduced ejection fraction) and chronic kidney disease (including end-stage kidney disease on hemodialysis).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:50:24.766721+00:00"}
{"study_id": 187885, "supplement_id": 1111, "safety_score": "30", "efficacy_score": 60, "quality_score": 70, "study_goal": "The researchers aimed to review the burden of anemia in chronic kidney disease, the limitations of current treatments like erythropoiesis-stimulating agents, and the potential benefits of hypoxia-inducible factor prolyl-hydroxylase inhibitors.", "results_summary": "The study found that erythropoiesis-stimulating agents are associated with increased risks of cardiovascular events, thrombosis, and mortality, particularly at high doses. Resistance to these agents remains a challenge, and new drugs targeting hypoxia-inducible factor pathways may offer advantages.", "population_specificity": "Patients with chronic kidney disease, particularly those on dialysis or with concurrent diabetes or high blood pressure.", "effective_dosage": "High doses (specific amounts not provided)", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:50:25.346593+00:00"}
{"study_id": 187889, "supplement_id": 1111, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the utility of erythropoiesis-stimulating agents (ESAs) in the prevention, diagnosis, and treatment of anemia throughout the perioperative period.", "results_summary": "The study highlights the importance of addressing anemia beyond transfusion-based approaches and provides evidence-based recommendations for anemia management, including the use of ESAs, though specific efficacy data is not detailed in the abstract.", "population_specificity": "Surgical patients throughout the perioperative period.", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:50:26.574047+00:00"}
{"study_id": 187888, "supplement_id": 1111, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the effects of heart failure treatments, including Erythropoiesis-Stimulating Agents, on exercise capacity and quality of life in patients with heart failure.", "results_summary": "The study found that Erythropoiesis-Stimulating Agents improved exercise capacity in anaemic patients with heart failure, though the evidence base for such interventions remains limited and not always consistent.", "population_specificity": "Anaemic patients with chronic heart failure.", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:50:26.930168+00:00"}
{"study_id": 187880, "supplement_id": 1111, "safety_score": "60", "efficacy_score": 70, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the therapeutic role of erythropoiesis-stimulating agents (ESAs) in improving morbidity and mortality in cardiovascular disease patients with anemia.", "results_summary": "Darbepoetin alfa improved quality of life metrics (Kansas City Cardiomyopathy Questionnaire scores) but showed no mortality benefits and was associated with increased adverse events. ESAs appear to enhance quality of life rather than survival in heart failure patients.", "population_specificity": "Patients with cardiovascular disease, specifically heart failure and anemia.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:50:28.146576+00:00"}
{"study_id": 187892, "supplement_id": 1111, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the role of erythropoiesis-stimulating agents in managing preoperative anemia, particularly for patients with multiple alloantibodies or religious objections to transfusion.", "results_summary": "The study found that erythropoiesis-stimulating agents may be considered for preoperative anemia management in specific cases, such as when iron supplementation is ineffective or there is insufficient time before surgery. The approach aims to reduce transfusion needs and improve patient outcomes.", "population_specificity": "Surgical patients with preoperative anemia, particularly those with iron-deficiency anemia, multiple alloantibodies, or religious objections to transfusion.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:50:29.220654+00:00"}
{"study_id": 187893, "supplement_id": 1111, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to understand the impact of erythropoiesis-stimulating agents (ESAs) on erythroferrone (ERFE) secretion in humans and validate a new ERFE immunoassay.", "results_summary": "The study found that ESA injections increased blood ERFE levels up to 8-fold in healthy volunteers, with a detection window of 13 days. Blood withdrawal also significantly increased ERFE, unaffected by iron supplementation, and exercise-induced muscle damage did not confound ERFE levels.", "population_specificity": "Healthy volunteers", "effective_dosage": "Not specified", "study_duration": "Detection window of 13 days post-intervention", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:50:30.785820+00:00"}
{"study_id": 187895, "supplement_id": 1111, "safety_score": "85", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the role of Erythropoiesis-Stimulating Agents (ESAs) in managing preoperative and postoperative anemia, particularly in conjunction with intravenous iron therapy.", "results_summary": "The study found that ESAs, when used with intravenous iron, are effective for moderate-to-severe iron deficiency anemia, especially in cases with short time to surgery or nonelective procedures. Minor infusion reactions to intravenous iron are rare, and severe anaphylactic reactions are extremely low, with no increased infection risk.", "population_specificity": "Patients undergoing major surgery with preoperative or postoperative anemia.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:50:33.803421+00:00"}
{"study_id": 187899, "supplement_id": 1111, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to develop consensus-based best practices for diagnosing and managing anemia and iron deficiency in postoperative surgical patients, including the use of Erythropoiesis-Stimulating Agents.", "results_summary": "The study developed evidence-based statements for diagnosing and managing postoperative anemia and iron deficiency, emphasizing practical approaches and identifying patients suitable for treatment. It highlighted the need for further large-scale clinical trials to address unmet medical needs.", "population_specificity": "Postoperative surgical patients with anemia or iron deficiency.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:50:35.290317+00:00"}
{"study_id": 187894, "supplement_id": 1111, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to evaluate the effects of molidustat, a hypoxia-inducible factor prolyl hydroxylase inhibitor, on iron metabolism in patients with anemia associated with chronic kidney disease (CKD).", "results_summary": "Molidustat improved iron availability in non-dialysis patients by decreasing transferrin saturation, hepcidin, ferritin, and iron concentrations while increasing total iron binding capacity. In hemodialysis patients, it increased transferrin saturation, ferritin, and iron concentrations but did not significantly alter hepcidin or total iron binding capacity.", "population_specificity": "Patients with anemia associated with CKD, including treatment-na\u00efve and previously ESA-treated patients not on dialysis, and previously ESA-treated patients on hemodialysis.", "effective_dosage": "Not specified", "study_duration": "16 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:50:35.449298+00:00"}
{"study_id": 187900, "supplement_id": 1111, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 60, "study_goal": "The researchers aimed to evaluate the effects of levocarnitine on renal anemia in hemodialysis patients, focusing on its potential to reduce the dosage of erythropoiesis-stimulating agents and improve erythropoiesis resistance index.", "results_summary": "The study suggests levocarnitine may improve renal anemia and cardiac functions in hemodialysis patients, potentially reducing the need for erythropoiesis-stimulating agents, but calls for further clinical studies to confirm efficacy.", "population_specificity": "Hemodialysis patients with carnitine deficiency.", "effective_dosage": "Not available", "study_duration": "Not available", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:50:35.513967+00:00"}
{"study_id": 187901, "supplement_id": 1111, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to discuss treatment possibilities for anaemia of inflammation, including the use of erythropoiesis-stimulating agents, biologicals, and hepcidin inhibitors.", "results_summary": "The abstract highlights that anaemia in immune-mediated GI disorders is commonly due to iron deficiency and inflammation, and suggests that parenteral administration of deficient factors, including high-dose IV iron formulations, can improve treatment compliance. It also mentions potential future treatments involving erythropoiesis-stimulating agents, though specific efficacy data is not detailed.", "population_specificity": "Patients with immune-mediated gastrointestinal disorders and associated anaemia.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:50:37.447399+00:00"}
{"study_id": 187902, "supplement_id": 1111, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 65, "study_goal": "The researchers aimed to assess the impact of a funding change for Erythropoiesis-Stimulating Agents (ESAs) on dialysis activity and hospital budgets in French public university hospitals.", "results_summary": "The study found mixed changes in dialysis activity under different funding hypotheses, with a negative budget impact for hospitals but a positive effect for the French National Health Insurance due to decreased ESA prices.", "population_specificity": "Dialysis patients in 37 University Public University Hospitals in Paris (10% of hospitalizations in France).", "effective_dosage": "Not specified", "study_duration": "March-September 2013 vs March-September 2014 (6 months per period)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:50:38.314772+00:00"}
{"study_id": 187898, "supplement_id": 1111, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to determine whether proactive, high-dose IV iron supplementation was noninferior to reactive, low-dose IV iron in hemodialysis patients receiving erythropoiesis-stimulating agents (ESA) for preventing cardiovascular events and mortality.", "results_summary": "The study randomized 2,141 hemodialysis patients to compare proactive high-dose IV iron (400 mg/month) with reactive low-dose IV iron, but final efficacy results were not yet reported as the trial was event-driven and ongoing. Baseline characteristics showed the cohort was representative of typical UK hemodialysis patients, with high ESA usage.", "population_specificity": "Incident hemodialysis adults with serum ferritin < 400 \u00b5g/L and transferrin saturation < 30%, predominantly male (65.3%), median age 65, and 79% white.", "effective_dosage": "Proactive arm: iron sucrose 400 mg/month unless ferritin > 700 \u00b5g/L or TSAT \u226540%; reactive arm: iron sucrose administered if ferritin <200 \u00b5g/L or TSAT < 20%.", "study_duration": "Expected follow-up of 2-4 years (ongoing at time of abstract).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:50:38.561561+00:00"}
{"study_id": 187903, "supplement_id": 1111, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 70, "study_goal": "The researchers aimed to investigate the prevalence of iron deficiency in non-dialysis chronic kidney disease patients receiving erythropoiesis-stimulating agents and compare the diagnostic criteria from two guidelines.", "results_summary": "The study found that iron deficiency is highly prevalent (48-78%) in non-dialysis chronic kidney disease patients on erythropoiesis-stimulating agents, with higher rates when using KDIGO-based criteria. Women showed more iron deficiency in early stages, while men had deficiencies at advanced stages, indicating inadequate iron supplementation in anemia management.", "population_specificity": "Non-dialysis chronic kidney disease patients (n=238) with eGFR <60 ml/min, predominantly female (61.8%), median age 71 years.", "effective_dosage": "Not specified", "study_duration": "5 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:50:40.573861+00:00"}
{"study_id": 187904, "supplement_id": 1111, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to assess the efficacy of preoperative intravenous iron infusion in optimizing hemoglobin levels in anemic colorectal cancer patients, comparing it to usual care without iron therapy.", "results_summary": "The study found that IV iron therapy significantly increased preoperative hemoglobin levels compared to usual care (0.65 mmol/L vs. 0.10 mmol/L, p < 0.001), with greater efficacy in patients exhibiting markers of absolute iron deficiency (higher transferrin and lower ferritin levels).", "population_specificity": "Anemic colorectal cancer patients undergoing surgery between 2010 and 2016 in a single teaching hospital.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:50:42.573658+00:00"}
{"study_id": 187908, "supplement_id": 1111, "safety_score": "75", "efficacy_score": 85, "quality_score": 70, "study_goal": "The researchers aimed to compare two methods of iron and ESA dosage adjustment in hemodialysis patients to determine if CHr-guided dosing reduces IV iron requirements while maintaining similar Hb levels.", "results_summary": "Group A (CHr-guided dosing) required significantly lower IV iron doses (-57.8%) than Group B (traditional monitoring), with no difference in ESA supplementation between groups. This approach reduced potential organ toxicity and lowered costs (~1 \u20ac/patient/month).", "population_specificity": "Patients undergoing hemodialysis with end-stage renal failure.", "effective_dosage": "Not specified", "study_duration": "8 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:50:43.657812+00:00"}
{"study_id": 187906, "supplement_id": 1111, "safety_score": "Not Assessed", "efficacy_score": 30, "quality_score": 75, "study_goal": "The researchers aimed to compare the efficacy and safety of intravenous iron sucrose versus oral ferrous sulfate in patients with malignancy and iron deficiency anemia not receiving erythropoiesis-stimulating agents (ESA).", "results_summary": "The study found no significant difference in hemoglobin increase, transfusion requirements, or quality of life between IV iron and oral iron groups. IV iron showed a marginally higher rate of hypersensitivity reactions compared to oral iron, but overall toxicity rates were similar.", "population_specificity": "Adult patients with malignancy requiring chemotherapy, hemoglobin <12 g/dL, and iron deficiency (ferritin <100 mcg/mL or transferrin saturation <20% or hypochromic RBCs >10%).", "effective_dosage": "Not specified", "study_duration": "6 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:50:45.182524+00:00"}
{"study_id": 187907, "supplement_id": 1111, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to identify the optimal iron levels for hemodialysis patients receiving recombinant human erythropoietin for anemia therapy.", "results_summary": "The study found that serum ferritin <90 ng/mL and transferrin saturation \u226520% were optimal for maintaining hemoglobin levels \u226510 g/dL in hemodialysis patients. Hepcidin showed a strong positive correlation with serum ferritin but no significant relationship with transferrin saturation.", "population_specificity": "208 outpatients on maintenance hemodialysis (64.9% male, mean age 59.3 \u00b1 13.1 years, median dialysis history 7.7 years).", "effective_dosage": "Low-dose iron supplement and recombinant human erythropoietin doses adjusted to maintain hemoglobin levels of 10-11 g/dL.", "study_duration": "1 year (July 2006 to June 2007).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:50:45.302196+00:00"}
{"study_id": 187909, "supplement_id": 1111, "safety_score": "Not Assessed", "efficacy_score": 50, "quality_score": 60, "study_goal": "The researchers aimed to review controversies surrounding the optimal management of CKD, including the appropriateness of erythropoiesis-stimulating agents (ESAs) for treating anemia.", "results_summary": "The abstract highlights ongoing controversies regarding the use of ESAs for anemia in CKD patients, noting that clinical guidelines differ dramatically in their recommendations. No specific efficacy or safety outcomes for ESAs are detailed.", "population_specificity": "Patients with chronic kidney disease (CKD).", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:50:45.727736+00:00"}
{"study_id": 187910, "supplement_id": 1111, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 70, "study_goal": "The researchers aimed to evaluate the role of Erythropoiesis-Stimulating Agents (ESAs) in managing anemia in children with chronic kidney disease (CKD) and explore challenges in maintaining hemoglobin levels.", "results_summary": "The study found that while ESAs and iron supplementation are core treatments for anemia in children with CKD, many remain anemic despite therapy. Higher ESA doses in adults have been linked to adverse outcomes, but this association has not been studied in children. Novel therapies may offer alternatives, but their safety and efficacy in pediatric CKD are unassessed.", "population_specificity": "Children with chronic kidney disease (CKD).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:50:47.447603+00:00"}
{"study_id": 187911, "supplement_id": 1111, "safety_score": "40", "efficacy_score": 70, "quality_score": 60, "study_goal": "The researchers aimed to assess the safety and efficacy of erythropoiesis-stimulating agents (ESAs) and IV iron in managing anemia in hemodialysis patients, focusing on potential cardiovascular and infection risks.", "results_summary": "The study highlights concerns about the long-term safety of IV iron, including risks of oxidative stress, bacterial growth, and potential links to cardiovascular events and infections, while noting that ESAs reduce anemia but may have cardiovascular safety concerns. Existing evidence on safety is limited due to insufficient power and short follow-up in trials, with observational studies yielding inconsistent results.", "population_specificity": "End-stage renal disease patients maintained by hemodialysis.", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:50:47.987166+00:00"}
{"study_id": 187912, "supplement_id": 1111, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to evaluate the role of hypoxia-inducible factors (HIFs) in erythropoiesis and iron metabolism as an alternative therapeutic approach for anemia in chronic kidney disease (CKD).", "results_summary": "The study found that pharmacologic activation of the HIF pathway stimulates erythropoiesis in CKD patients with anemia, and clinical studies support the continued evaluation of HIF prolyl hydroxylase inhibitors for this purpose.", "population_specificity": "Patients with chronic kidney disease (CKD) and anemia.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:50:48.714700+00:00"}
{"study_id": 187913, "supplement_id": 1111, "safety_score": "75", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to compare the efficacy and safety of intravenous versus oral iron supplementation in patients with chronic kidney disease (CKD) stages 3 to 5D, focusing on hemoglobin response and adverse events.", "results_summary": "IV iron was more effective than oral iron in increasing hemoglobin levels (>1g/dL) in both CKD stages 3-5 and 5D, with similar safety profiles except for a higher risk of hypotension and fewer gastrointestinal adverse events with IV iron.", "population_specificity": "Patients with CKD stages 3 to 5 or 5D.", "effective_dosage": "Not specified in the abstract.", "study_duration": "Follow-up was usually limited to 3 months.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:50:51.322531+00:00"}
{"study_id": 187914, "supplement_id": 1111, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 60, "study_goal": "The researchers aimed to review the pathogenesis of anaemia of chronic disease and suggest future therapeutic targets, including the use of erythropoiesis-stimulating agents.", "results_summary": "The study highlights the role of cytokines and acute-phase proteins in anaemia of chronic disease and suggests erythropoiesis-stimulating agents as a treatment option, alongside iron supplementation and blood transfusion.", "population_specificity": "Chronically ill patients with anaemia.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:50:51.641629+00:00"}
{"study_id": 187917, "supplement_id": 1111, "safety_score": "80", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to compare the benefits and harms of iron supplementation alone and as an adjunct to erythropoiesis-stimulating agents (ESAs) versus ESA alone in treating chemotherapy-induced anemia.", "results_summary": "The study found that adding iron to ESAs improves hematopoietic response, reduces the need for red blood cell transfusions, and increases hemoglobin levels, with parenteral iron showing superiority over oral iron. The treatment was well tolerated.", "population_specificity": "Patients with chemotherapy-induced anemia.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:50:53.407885+00:00"}
{"study_id": 187916, "supplement_id": 1111, "safety_score": "30", "efficacy_score": 40, "quality_score": 70, "study_goal": "The researchers aimed to summarize current therapeutic strategies for managing anemia in CKD patients with concomitant cancer, focusing on the risks and benefits of ESAs.", "results_summary": "The study found that ESAs are associated with higher risks of cerebrovascular events and increased mortality without improving cardiovascular outcomes in CKD patients, with particularly negative results in cancer patients. This has led to decreased ESA usage and increased reliance on iron substitution and alternative therapies.", "population_specificity": "Chronic kidney disease (CKD) patients with concomitant cancer.", "effective_dosage": "Not Assessed", "study_duration": "Not Assessed", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:50:53.675646+00:00"}
{"study_id": 187915, "supplement_id": 1111, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the efficacy of ferric pyrophosphate citrate and determine its role in therapy for reducing the need for erythropoiesis-stimulating agents and intravenous iron supplementation.", "results_summary": "Ferric pyrophosphate citrate was found to reduce the dose of erythropoiesis-stimulating agents and intravenous iron supplementation while increasing serum ferritin concentrations in hemodialysis patients. The study suggests it is a viable option for maintaining hemoglobin, transferrin saturation, and ferritin levels.", "population_specificity": "Patients with stage 5 chronic kidney disease receiving hemodialysis.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:50:54.833552+00:00"}
{"study_id": 187918, "supplement_id": 1111, "safety_score": "70", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the efficacy, safety, and emerging alternatives to current erythropoiesis-stimulating agents (ESAs) for treating chronic kidney disease (CKD)-associated anemia.", "results_summary": "Current peptidic ESAs are effective and well-tolerated but costly and require parenteral administration, with potential resistance development. Investigational alternatives like HIF stabilizers (e.g., molidustat, daprodustat) and GDF11 ligand traps (e.g., sotatercept) show promise but raise safety concerns due to pleiotropic effects and immunogenicity.", "population_specificity": "Patients with chronic kidney disease (CKD)-associated anemia.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:50:56.586219+00:00"}
{"study_id": 187920, "supplement_id": 1111, "safety_score": "85", "efficacy_score": 80, "quality_score": 90, "study_goal": "The researchers aimed to evaluate the benefits and harms of using iron as a supplement to Erythropoiesis-Stimulating Agents (ESAs) or iron alone compared with ESA alone in managing chemotherapy-induced anemia (CIA).", "results_summary": "The study found that adding iron to ESAs improved hematopoietic response, reduced the need for red blood cell transfusions, and increased hemoglobin levels without significant differences in quality of life or thromboembolic events. No evidence was found for differences in overall survival or treatment-related mortality.", "population_specificity": "Patients with chemotherapy-induced anemia (2087 participants across 8 RCTs).", "effective_dosage": "Not specified in the abstract.", "study_duration": "Up to 20 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:50:58.334522+00:00"}
{"study_id": 187921, "supplement_id": 1111, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to evaluate the effectiveness of ferric citrate and ferric pyrophosphate citrate in reducing IV iron and ESA requirements in hemodialysis patients.", "results_summary": "Ferric citrate increased serum ferritin, hemoglobin, and transferrin saturation while reducing IV iron and ESA needs. Ferric pyrophosphate citrate also demonstrated effective iron delivery and stable hemoglobin levels with reduced ESA and IV iron requirements.", "population_specificity": "Patients receiving maintenance hemodialysis.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:50:59.358370+00:00"}
{"study_id": 187919, "supplement_id": 1111, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to examine treatment patterns for chemotherapy-induced anemia (CIA) with erythropoiesis-stimulating agents (ESAs) across different calendar periods following changes in US prescribing information.", "results_summary": "The study found a significant decrease in ESA use (28% to 3%) and an increase in RBC transfusions (8% to 16%) over three calendar periods. Hb concentration prior to ESA use showed a decreasing trend, while no difference was observed for transfusions.", "population_specificity": "Patients diagnosed with breast, lung, colorectal, ovarian, or gastric cancer (2000-2012) who developed grade 2+ CIA (Hb <10 g/dl).", "effective_dosage": "Not specified", "study_duration": "January 1, 2000-June 30, 2013 (observational periods: P1: 2000-2006, P2: 2007-2010, P3: 2010-2013)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:50:59.518201+00:00"}
{"study_id": 187922, "supplement_id": 1111, "safety_score": "45", "efficacy_score": 60, "quality_score": 70, "study_goal": "The researchers aimed to evaluate the long-term safety of high-dose intravenous iron supplementation in CKD patients with anemia, focusing on mortality, cardiovascular risks, and infection risks.", "results_summary": "The study highlights concerns about the long-term safety of high-dose intravenous iron supplementation, noting conflicting observational data and insufficiently powered clinical trials. It suggests a cautious approach with lower target ferritin/TSAT levels until definitive safety data is available.", "population_specificity": "Chronic kidney disease (CKD) patients with anemia, particularly dialysis patients.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:51:00.034854+00:00"}
{"study_id": 187924, "supplement_id": 1111, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to evaluate the potential of novel iron-containing phosphate binders to reduce the need for erythropoiesis-stimulating agents and IV iron in managing anemia in hemodialysis patients.", "results_summary": "The study found that iron-containing phosphate binders like ferric citrate may effectively replete iron stores and improve anemia in CKD patients, challenging previous assumptions about oral iron inefficiency. However, long-term safety data for these binders are lacking.", "population_specificity": "Patients on maintenance hemodialysis (MHD) with chronic kidney disease (CKD).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:51:01.658701+00:00"}
{"study_id": 187923, "supplement_id": 1111, "safety_score": "85", "efficacy_score": 90, "quality_score": 95, "study_goal": "The researchers aimed to determine whether ferric pyrophosphate citrate (FPC) administered via dialysate could effectively replace iron losses and maintain hemoglobin levels in hemodialysis patients without increasing iron stores.", "results_summary": "FPC maintained hemoglobin levels and reduced iron loss compared to placebo, with no significant difference in adverse events between groups. The treatment also showed significant benefits in reticulocyte hemoglobin content and serum ferritin levels.", "population_specificity": "599 iron-replete chronic hemodialysis patients.", "effective_dosage": "2 \u00b5M FPC-iron via dialysate during hemodialysis.", "study_duration": "Up to 48 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:51:02.131583+00:00"}
{"study_id": 187925, "supplement_id": 1111, "safety_score": "60", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to identify common causes of ESA hyporesponsiveness in ESRD patients and evaluate potential therapeutic interventions to improve ESA efficacy.", "results_summary": "The study found that ESA hyporesponsiveness in ESRD patients is often caused by iron deficiency, inflammation, and other factors, and can be improved by interventions like iron administration, biocompatible hemodialysis membranes, and vitamin supplementation. However, iron administration was associated with increased infection and atherosclerosis risks.", "population_specificity": "Patients with end-stage renal disease (ESRD) exhibiting hyporesponsiveness to ESAs.", "effective_dosage": "Higher than 300 IU/kg/week of epoetin or 1.5 mg/kg/week of darbepoetin.", "study_duration": "Not specified.", "interactions": "Angiotensin-converting enzyme inhibitors, angiotensin receptor blockers, myelosuppressive agents, and others mentioned as contributing to hyporesponsiveness.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:51:04.813828+00:00"}
{"study_id": 187926, "supplement_id": 1111, "safety_score": "40", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to review the potential risks and complications of long-term intravenous iron supplementation as an alternative to erythropoiesis-stimulating agents for treating anemia in chronic kidney disease (CKD).", "results_summary": "The study highlights concerns about cardiac complications and severe infections from long-term intravenous iron use, noting that while short-term safety appears acceptable, long-term risks remain poorly understood. It also discusses the potential toxicity of labile iron in CKD complications.", "population_specificity": "Patients with chronic kidney disease (CKD) and anemia.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:51:05.010359+00:00"}
{"study_id": 187927, "supplement_id": 1111, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to develop a more accurate and generalizable machine learning model for predicting individual patient responses to ESA/Iron therapy in CKD anemia, accounting for population diversity.", "results_summary": "The ML model, incorporating human physiology and drug pharmacology, achieved superior prediction accuracy (MAE \u2264 0.6 g/dl Hb) across Spain, Italy, and Portugal, outperforming previous approaches. It addressed variability in patient responses and treatment stages.", "population_specificity": "CKD patients with anemia in Spain, Italy, and Portugal.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:51:06.741854+00:00"}
{"study_id": 187930, "supplement_id": 1111, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 60, "study_goal": "The researchers aimed to explore the optimal hemoglobin targets for ESA use, safety concerns, and new strategies like HIF manipulation and activin A pathway regulation for treating anemia in CKD.", "results_summary": "The study highlights unresolved questions about ESA safety and iron supplementation limits, while identifying HIF system manipulation and activin A pathway regulation as promising new approaches. New intravenous iron molecules may reduce dosing frequency.", "population_specificity": "Patients with chronic kidney disease (CKD)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:51:08.282349+00:00"}
{"study_id": 187929, "supplement_id": 1111, "safety_score": "75", "efficacy_score": 80, "quality_score": 70, "study_goal": "The researchers aimed to evaluate the impact of restrictive ESA reimbursement criteria and intravenous iron supplementation on managing anemia in CKD patients in Taiwan.", "results_summary": "The study found that using lower ESA doses and early intravenous iron supplementation effectively achieved reasonable hemoglobin targets (10-11 g/dL) in CKD patients, avoiding cardiovascular risks associated with higher ESA doses. Taiwan's approach demonstrated better safety and efficacy compared to global practices.", "population_specificity": "Chronic kidney disease (CKD) patients, both non-dialysis and dialysis-dependent.", "effective_dosage": "Maximal dose of epoetin-\u03b1 or \u03b2 was 20,000 U per month.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:51:08.771625+00:00"}
{"study_id": 187931, "supplement_id": 1111, "safety_score": "60", "efficacy_score": 70, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the risks and benefits of iron administration alongside erythropoiesis-stimulating agents (ESAs) in CKD patients and propose a pharmacometric approach for individualized dosing.", "results_summary": "The study highlights the challenges of balancing ESA and iron supplementation in CKD patients, noting potential risks of excessive iron dosing and the lack of systematic monitoring for iron overload. It suggests a need for individualized dosing strategies but does not provide conclusive efficacy or safety data for ESAs alone.", "population_specificity": "Patients with chronic kidney disease (CKD)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:51:10.069895+00:00"}
{"study_id": 187928, "supplement_id": 1111, "safety_score": "75", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to assess the effectiveness and safety of iron supplementation in CKD Stage 5 patients not yet on dialysis who were treated with erythropoiesis-stimulating agents (ESAs).", "results_summary": "Iron supplementation was associated with a 15% lower risk of death and reduced hospitalizations but a slightly higher risk of faster progression to end-stage renal disease. The survival benefit was consistent across most dosage groups except for those receiving monthly IV iron >200 mg.", "population_specificity": "Adult CKD Stage 5 patients not on dialysis, with serum creatinine >6 mg/dL and hematocrit <28%, treated with ESAs.", "effective_dosage": "Monthly IV iron >200 mg was noted as less effective; other dosages were not specified.", "study_duration": "Follow-up until dialysis, death, or 31 December 2009 (study period: 2000-2009).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:51:10.278642+00:00"}
{"study_id": 187932, "supplement_id": 1111, "safety_score": "Not Assessed", "efficacy_score": 45, "quality_score": 85, "study_goal": "The researchers aimed to determine whether online hemodiafiltration (HDF) reduces erythropoiesis-stimulating agent (ESA) resistance compared to low-flux hemodialysis (HD) in chronic hemodialysis patients.", "results_summary": "The study found no significant difference in ESA resistance between HDF and HD treatments, with similar ESA index values over 12 months. HDF-treated patients showed slightly lower transferrin saturation and ferritin levels but received marginally more iron supplementation.", "population_specificity": "Patients undergoing chronic hemodialysis treatment.", "effective_dosage": "Not specified (ESA dose measured as weight-adjusted weekly dose in daily defined doses [DDD]/hematocrit).", "study_duration": "12 months.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:51:11.327876+00:00"}
{"study_id": 187933, "supplement_id": 1111, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to investigate the association between vitamin D deficiency and ESA resistance in CKD patients, exploring potential mechanisms and therapeutic benefits of vitamin D supplementation.", "results_summary": "The study found that vitamin D deficiency is linked to ESA resistance and anemia in CKD patients, likely due to inflammation and impaired erythropoiesis. Vitamin D supplementation improved anemia and reduced ESA requirements, independent of PTH suppression, possibly through anti-inflammatory effects and direct stimulation of erythroid progenitors.", "population_specificity": "Patients with chronic kidney disease (CKD)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:51:13.271623+00:00"}
{"study_id": 187934, "supplement_id": 1111, "safety_score": "85", "efficacy_score": 80, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the safety, efficacy, and impact of Erythropoiesis-Stimulating Agents (ESAs) on hemoglobin response, quality of life, and adverse events in patients with lymphoproliferative malignancies, particularly multiple myeloma.", "results_summary": "The study found that ESAs were safe and effective, with 69.1% of patients achieving a hemoglobin response (>2g/dl increase). Iron supplementation improved response rates and reduced costs, while HYPO% was a significant predictor for hemoglobin response and iron need.", "population_specificity": "Patients with lymphoproliferative malignancies, especially multiple myeloma.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:51:13.716367+00:00"}
{"study_id": 187935, "supplement_id": 1111, "safety_score": "Not Assessed", "efficacy_score": 60, "quality_score": 75, "study_goal": "The researchers aimed to review the role of hepcidin in CKD-related anemia and explore potential treatments to lower serum hepcidin levels to improve anemia and reduce ESA resistance.", "results_summary": "The study found that elevated hepcidin levels in CKD patients contribute to anemia and ESA resistance, partially corrected by parenteral iron, but ESA dose requirements remain high. Investigational treatments targeting hepcidin may restore iron homeostasis and improve anemia.", "population_specificity": "Chronic kidney disease (CKD) patients with anemia.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:51:14.469615+00:00"}
{"study_id": 187937, "supplement_id": 1111, "safety_score": "80", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to evaluate the safety, efficacy, and preferred administration routes of intravenous iron supplementation in CKD patients receiving erythropoiesis-stimulating agents.", "results_summary": "Intravenous iron significantly increased hemoglobin levels compared to oral iron, with fewer gastrointestinal side effects and a low rate of adverse events. It also showed potential to delay or avoid the need for erythropoiesis-stimulating agents in some nondialysis CKD patients.", "population_specificity": "Chronic kidney disease (CKD) patients, both dialysis-dependent and nondialysis-dependent, with anemia.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:51:16.785195+00:00"}
{"study_id": 187936, "supplement_id": 1111, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to determine the association between baseline C-reactive protein (CRP) levels and treatment response in solid tumor patients with chemotherapy-induced anemia receiving erythropoiesis-stimulating agents (ESA) and iron supplementation.", "results_summary": "The study found that high baseline CRP levels predicted a poor response to ESA and iron treatment, with a significant negative correlation between CRP and final hemoglobin levels. 65% of patients achieved hemoglobin \u2265 11 g/dL after treatment, with a mean increase of 0.86 g/dL.", "population_specificity": "Adult patients with solid tumors undergoing chemotherapy, predominantly male (64%), with advanced disease stages (85.7% at stages III-IV).", "effective_dosage": "Not specified", "study_duration": "Median of 85 days (up to 16 weeks)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:51:17.512797+00:00"}
{"study_id": 187938, "supplement_id": 1111, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to compare the cost-effectiveness and cost-utility of parenteral iron therapy versus oral iron in haemodialysis patients receiving erythropoiesis-stimulating agents (ESAs).", "results_summary": "Parenteral iron was found to be cost-effective compared to oral iron, with incremental cost-effectiveness ratios of $74,760 per life year saved and $34,660 per QALY gained. Achieving Hb targets with parenteral iron reduced ESA doses and lowered mortality risk associated with very low Hb levels (<9.0 g/dL).", "population_specificity": "Haemodialysis patients with relative iron deficiency.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:51:19.192737+00:00"}
{"study_id": 187939, "supplement_id": 1111, "safety_score": "30", "efficacy_score": 70, "quality_score": 85, "study_goal": "The researchers aimed to assess the risk of hepatic iron overload in hemodialysis patients receiving erythropoiesis-stimulating agents (ESA) and parenteral iron supplementation.", "results_summary": "The study found that 84% of patients had mild to severe hepatic iron overload, with 36% showing severe overload. Iron withdrawal or dose reduction significantly reduced iron stores, suggesting a need for revised iron therapy guidelines.", "population_specificity": "119 fit hemodialysis patients receiving ESA and parenteral iron.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:51:19.527016+00:00"}
{"study_id": 187940, "supplement_id": 1111, "safety_score": "85", "efficacy_score": 90, "quality_score": 88, "study_goal": "The researchers aimed to determine whether intravenous (IV) iron, when added to erythropoiesis-stimulating agents (ESA), improves haematopoietic response and reduces red blood cell transfusion requirements in chemotherapy-induced anaemia (CIA).", "results_summary": "IV iron significantly increased haematopoietic response rates and decreased transfusion requirements in patients receiving ESA, with no difference in mortality or adverse events compared to controls. The effect was dose-dependent and consistent regardless of baseline iron status.", "population_specificity": "Patients with chemotherapy-induced anaemia (CIA), primarily those receiving ESA (1562 out of 1681 patients).", "effective_dosage": "Not specified in the abstract.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:51:20.660187+00:00"}
{"study_id": 187942, "supplement_id": 1111, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to evaluate current evidence on hemoglobin targets for anemia treatment in CKD and ESRD patients, including the use of ESAs, biosimilar erythropoietins, and novel investigational strategies.", "results_summary": "The study highlights that ESAs, combined with iron supplementation, are central to anemia correction in CKD, but recommends conservative, individualized dosing. It also discusses promising new treatments like peginesatide and prolyl hydroxylase inhibitors, as well as high-dose iron formulations.", "population_specificity": "Chronic kidney disease (CKD) and end-stage renal disease (ESRD) patients.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:51:22.429668+00:00"}
{"study_id": 187941, "supplement_id": 1111, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 75, "study_goal": "The researchers aimed to compare the efficacy of intravenous (i.v.) versus oral iron supplementation for treating iron deficiency in non-hemodialysis-dependent chronic kidney disease (CKD) patients, particularly those treated with erythropoiesis-stimulating agents (ESAs).", "results_summary": "The study found that i.v. iron was superior to oral iron in increasing ferritin and transferrin saturation (TSAT) levels but did not consistently raise hemoglobin levels. No significant difference was observed in ESA dosage requirements between the two iron formulations.", "population_specificity": "Non-hemodialysis-dependent patients with chronic kidney disease (CKD), including those treated with ESAs.", "effective_dosage": "Not specified", "study_duration": "21 days to six months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:51:22.469469+00:00"}
{"study_id": 187943, "supplement_id": 1111, "safety_score": "40", "efficacy_score": 70, "quality_score": 85, "study_goal": "The researchers aimed to evaluate the safety and efficacy of Erythropoiesis-Stimulating Agents (ESAs) in treating anemia in adult cancer patients, particularly those undergoing chemotherapy, and to update clinical guidelines accordingly.", "results_summary": "The study highlights that ESAs can correct anemia in cancer patients but notes recent findings of detrimental health effects, leading to FDA label revisions and updated NCCN Guidelines. The guidelines emphasize individualized treatment based on patient condition.", "population_specificity": "Adult cancer patients, especially those receiving chemotherapy.", "effective_dosage": "Not Assessed", "study_duration": "Not Assessed", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:51:22.531481+00:00"}
{"study_id": 187944, "supplement_id": 1111, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 70, "study_goal": "The researchers aimed to investigate the association between serum ferritin levels, ESA dosage, and hemoglobin cycling in hemodialysis patients.", "results_summary": "The study found that hemoglobin cycling was closely associated with variations in iron storage (ferritin levels), with stable iron storage and ESA dosage being important for maintaining stable hemoglobin levels. Patients with oral or no iron supplementation had lower ferritin fluctuations compared to those receiving intravenous iron.", "population_specificity": "266 hemodialysis patients", "effective_dosage": "Not specified", "study_duration": "12 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:51:24.871911+00:00"}
{"study_id": 187945, "supplement_id": 1111, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the potential of erythropoiesis-stimulating agents (like darbepoetin alfa) and intravenous iron to treat anemia in chronic heart failure patients and assess their impact on clinical outcomes.", "results_summary": "The abstract suggests that intravenous iron (e.g., iron carboxymaltose) improves symptoms and quality of life in chronic HF patients, while the efficacy of darbepoetin alfa in reducing mortality or hospitalization is pending results from the RED-HF study.", "population_specificity": "Patients with chronic heart failure and anemia.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:51:25.638026+00:00"}
{"study_id": 187946, "supplement_id": 1111, "safety_score": "85", "efficacy_score": 80, "quality_score": 90, "study_goal": "The researchers aimed to determine whether iron supplementation (parenteral or oral) improves the hematopoietic response and reduces transfusion risk when combined with erythropoiesis-stimulating agents (ESAs) in anemic cancer patients.", "results_summary": "Parenteral iron significantly increased hematopoietic response (RR 1.29) and reduced transfusion risk (RR 0.77), while oral iron showed no significant benefits. The time to achieve hematopoietic response was shortened by 1 month, and no increased toxicity was observed with iron supplementation.", "population_specificity": "Anemic cancer patients undergoing chemotherapy.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:51:27.661740+00:00"}
{"study_id": 187948, "supplement_id": 1111, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the potential benefits and safety concerns of erythropoiesis-stimulating agents in patients with heart failure and anemia.", "results_summary": "The abstract suggests that erythropoiesis-stimulating agents might benefit patients with HF and anemia, but safety concerns, particularly in chronic kidney disease, remain unresolved pending further large-scale trials.", "population_specificity": "Patients with heart failure (HF) and anemia, including those with and without iron deficiency.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:51:28.325500+00:00"}
{"study_id": 187947, "supplement_id": 1111, "safety_score": "30", "efficacy_score": 50, "quality_score": 70, "study_goal": "The researchers aimed to review the potential adverse effects of overzealous use of erythropoiesis-stimulating agents (ESAs) and intravenous iron in managing anemia in CKD and ESRD patients.", "results_summary": "The study found that higher hemoglobin targets with ESAs and intravenous iron were associated with more adverse outcomes, including oxidative stress, endothelial dysfunction, inflammation, impaired immunity, and renal injury. Retrospective analysis suggested higher morbidity in patients who required higher doses of ESAs and iron to achieve targets.", "population_specificity": "Patients with chronic kidney disease (CKD) and end-stage renal disease (ESRD).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:51:28.508466+00:00"}
{"study_id": 187950, "supplement_id": 1111, "safety_score": "60", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to determine whether targeting higher hemoglobin levels with Erythropoiesis-Stimulating Agents (ESAs) or achieving those levels is associated with increased cardiovascular risks in CKD patients.", "results_summary": "The study found that targeting higher hemoglobin levels with ESAs was linked to higher cardiovascular events, but achieving these levels did not show the same risk. Individualized ESA dosing and proactive management are recommended to optimize outcomes.", "population_specificity": "Chronic Kidney Disease (CKD) patients.", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:51:30.667071+00:00"}
{"study_id": 187951, "supplement_id": 1111, "safety_score": "80", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the role of intravenous iron therapy in improving the response to erythropoiesis-stimulating agents (ESAs) in patients with cancer-related anemia.", "results_summary": "The study found that i.v. iron supplementation improves ESA response rates, reduces time to target hemoglobin levels, decreases ESA requirements, and is more effective than oral iron without increased toxicity. However, i.v. iron remains underutilized due to misinformation about adverse events.", "population_specificity": "Patients with cancer-related anemia, particularly those with absolute or functional iron deficiency.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:51:30.749283+00:00"}
{"study_id": 187949, "supplement_id": 1111, "safety_score": "75", "efficacy_score": 80, "quality_score": 70, "study_goal": "The researchers aimed to review advancements in erythropoiesis-stimulating agents (ESAs) and iron supplementation for anemia correction in chronic kidney disease patients, including new molecular modifications and alternative strategies.", "results_summary": "The study found that ESAs, combined with iron supplementation, remain a primary treatment for anemia in chronic kidney disease. Newer agents, including small peptides and hypoxia-inducible transcription factor stabilizers, show promise, with some offering oral administration. New iron formulations allow high-dose administration with minimal free iron release and a good safety profile, though long-term data are still needed.", "population_specificity": "Chronic kidney disease patients with anemia.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:51:31.472797+00:00"}
{"study_id": 187952, "supplement_id": 1111, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to compare the clinical and economic outcomes of CIA patients treated with fixed dosing regimens of epoetin alfa (EPO) versus darbepoetin alfa (DARB).", "results_summary": "EPO patients showed greater hemoglobin improvement and lower transfusion rates compared to DARB patients, with significantly lower cumulative costs. The EPO-to-DARB dose ratio was 169:1.", "population_specificity": "Patients with chemotherapy-induced anemia (CIA) treated in 44 clinical centers.", "effective_dosage": "EPO 40,000 Units or DARB 500 micrograms.", "study_duration": "Data collected from January 1, 2006, to May 8, 2009 (specific intervention duration not stated).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:51:34.393123+00:00"}
{"study_id": 187953, "supplement_id": 1111, "safety_score": "70", "efficacy_score": 50, "quality_score": 85, "study_goal": "The researchers aimed to determine whether coadministration of parenteral iron improves the efficacy of erythropoiesis-stimulating agents (ESAs) in patients with chemotherapy-associated anemia (CAA).", "results_summary": "The study found no significant difference in erythropoietic response rates, transfusion requirements, or quality of life between patients receiving IV iron, oral iron, or placebo alongside darbepoetin alfa. Adverse events were more common in the IV iron group, though not statistically significant.", "population_specificity": "Patients with hemoglobin <11 g/dL undergoing chemotherapy for nonmyeloid malignancies.", "effective_dosage": "Darbepoetin alfa once every 3 weeks; ferric gluconate 187.5 mg IV every 3 weeks or oral ferrous sulfate 325 mg daily.", "study_duration": "16 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:51:35.500821+00:00"}
{"study_id": 187954, "supplement_id": 1111, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 70, "study_goal": "The researchers aimed to determine whether vitamin D insufficiency is associated with lower hemoglobin levels and ESA resistance in patients on maintenance hemodialysis.", "results_summary": "The study found that serum 25(OH)D(3) concentration was significantly correlated with hemoglobin levels and ESA dose/Hb index, suggesting an independent association between vitamin D levels and erythropoietin responsiveness in CKD patients on hemodialysis.", "population_specificity": "Patients with chronic kidney disease on maintenance hemodialysis.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:51:35.613813+00:00"}
{"study_id": 187955, "supplement_id": 1111, "safety_score": "60", "efficacy_score": 75, "quality_score": 70, "study_goal": "The researchers aimed to compare epoetin alfa prescribing practices before and after FDA black box warnings and evaluate the appropriateness of efficacy and toxicity monitoring.", "results_summary": "After safety advisory changes, prescribing habits improved with more metastatic patients and fewer cardiovascular patients receiving epoetin alfa, lower hemoglobin levels at initiation, more dose adjustments for excessive responders, and fewer blood transfusions. However, blood pressure control, iron studies, and supplementation did not improve.", "population_specificity": "Patients with chemotherapy-induced anemia at National Cancer Centre Singapore.", "effective_dosage": "Not specified", "study_duration": "January 1, 2005 to December 10, 2009 (retrospective review periods)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:51:37.049545+00:00"}
{"study_id": 13259, "supplement_id": 1112, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to characterize proteins isolated from porcine heart using different extraction methods (aqueous or saline solutions, with or without sodium nitrite) and evaluate their nutritional and functional properties.", "results_summary": "The study found that all essential amino acids (EAAs) were present in the isolates, with higher EAA index and estimated protein efficiency in aqueous-extracted isolates (HPIaq) compared to saline-extracted ones (HPIsal). The isolates showed high levels of iron and calcium, with saline extraction increasing sodium and heme iron content.", "population_specificity": "Not specified (in vitro study on porcine heart protein isolates).", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:51:39.769455+00:00"}
{"study_id": 187956, "supplement_id": 1111, "safety_score": "75", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the safety, efficacy, and clinical advantages of newer intravenous iron formulations, including ferric carboxymaltose, compared to older agents like iron dextran, in treating iron-deficiency anaemia, particularly in patients requiring erythropoiesis-stimulating agents (ESAs).", "results_summary": "The study found that second-generation intravenous iron formulations (e.g., iron sucrose, ferric gluconate) are safer and more effective than iron dextran, with fewer serious adverse events. Ferric carboxymaltose was highlighted as a superior option, enabling rapid correction of iron-deficiency anaemia with a single high-dose administration. However, concerns about long-term toxicity (e.g., atherosclerosis, infection) remain unresolved.", "population_specificity": "Patients with iron-deficiency anaemia, including those with chronic conditions such as chronic kidney disease and those requiring haemodialysis.", "effective_dosage": "Up to 400 mg/month for some formulations; ferric carboxymaltose allows single-dose administration of 1000 mg.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:51:40.682380+00:00"}
{"study_id": 187957, "supplement_id": 1111, "safety_score": "85", "efficacy_score": 90, "quality_score": 80, "study_goal": "The researchers aimed to compare the effectiveness and safety of intravenous versus oral iron supplementation in managing iron-deficiency anaemia in non-dialysis chronic kidney disease (ND-CKD) patients, with or without erythropoiesis-stimulating agents (ESAs).", "results_summary": "Intravenous iron was more effective than oral iron in increasing haemoglobin levels in ND-CKD patients, with newer preparations (ferric carboxymaltose and ferumoxytol) showing rapid, high-dose administration benefits. Some patients unresponsive to oral iron later responded to intravenous iron, and modern preparations demonstrated a good safety profile without anaphylaxis.", "population_specificity": "Non-dialysis chronic kidney disease (ND-CKD) patients with iron-deficiency anaemia.", "effective_dosage": "Single 15-minute injection of ferric carboxymaltose, with up to two additional doses as needed.", "study_duration": "Up to 56 days.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:51:41.501220+00:00"}
{"study_id": 13260, "supplement_id": 1112, "safety_score": "Not Assessed", "efficacy_score": 20, "quality_score": 75, "study_goal": "The researchers aimed to investigate whether gut microbiota contribute essential amino acids (EAAs) to host tissues in mice with reconstituted microbiomes.", "results_summary": "The study found no evidence of microbial EAA contributions to host tissues, with similar 13C-EAA patterns observed in germ-free and conventionalized mice. The findings suggest reconstituted gut microbiomes may not functionally provision EAAs under the tested conditions.", "population_specificity": "Germ-free and conventionalized mice", "effective_dosage": "High-protein diet (18%) for germ-free mice, low-protein diet (10%) for conventionalized mice", "study_duration": "20-day dietary intervention following 30-day microbiome reconstitution", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:51:41.708383+00:00"}
{"study_id": 13261, "supplement_id": 1112, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 75, "study_goal": "The researchers aimed to determine how different photoperiods affect the essential amino acid (EAA) composition in juvenile fat greenling (Hexagrammos otakii).", "results_summary": "The study found that photoperiod significantly influenced EAA composition, with EAAs being sharply consumed in the 12L:12D and 24L treatments to adapt to environmental stress, while the 24D group showed better growth and body composition.", "population_specificity": "Juvenile fat greenling (Hexagrammos otakii) with an initial weight of 11.07 \u00b1 0.16 g.", "effective_dosage": "Not specified (photoperiod treatments: 12L:12D, 24L, 24D).", "study_duration": "30 days.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:51:43.536627+00:00"}
{"study_id": 16540, "supplement_id": 1145, "safety_score": "85", "efficacy_score": 80, "quality_score": 90, "study_goal": "The researchers aimed to determine the long-term effects of anthocyanin-rich fruit juice on Nrf2-dependent transcription, antioxidant response, and gut microbiota in healthy volunteers.", "results_summary": "Long-term consumption of anthocyanin-rich fruit juice significantly increased NQO-1 and HO-1 transcript levels in peripheral blood lymphocytes, indicating systemic effects. The juice also significantly affected the gut microbiota, with individual Nrf2 genotypes influencing the antioxidant response.", "population_specificity": "57 healthy male volunteers", "effective_dosage": "Not specified", "study_duration": "Nine weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:51:51.329259+00:00"}
{"study_id": 16543, "supplement_id": 1145, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to identify and evaluate the anti-inflammatory compounds in Hawaiian Noni fruit juice and their mechanisms of action in LPS-stimulated macrophages.", "results_summary": "Five compounds in Noni fruit juice demonstrated anti-inflammatory activity by inhibiting nitric oxide production and downregulating key inflammatory markers (IKK\u03b1/\u03b2, I-\u03baB\u03b1, NF-\u03baB p65, nitric oxide synthase, and cyclooxygenase-2) in LPS-stimulated macrophages.", "population_specificity": "LPS-stimulated RAW 264.7 macrophages (in vitro study).", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:51:51.932854+00:00"}
{"study_id": 189116, "supplement_id": 1144, "safety_score": "75", "efficacy_score": 80, "quality_score": 85, "study_goal": "The researchers aimed to determine whether adding fructose to glucose supplementation before exercise modifies endothelial reactivity, glucoregulation, and ischemic reactive hyperemia during anaerobic and aerobic exercise.", "results_summary": "Fructose supplementation before anaerobic exercise increased ischemic reactive hyperemia, improved nitric oxide bioavailability, and altered glucoregulation compared to glucose alone, but no significant effects were observed during aerobic exercise. Fructose also led to higher residual lactate and, during aerobic exercise, increased plasma lipoperoxides.", "population_specificity": "Twenty physically trained men.", "effective_dosage": "Not specified (oral dose of glucose or glucose plus fructose).", "study_duration": "Single 30-minute exercise session.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:51:52.275671+00:00"}
{"study_id": 16544, "supplement_id": 1145, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to develop and evaluate a thermophilic endo-polygalacturonase (PoxaEnPG28B-Pp) for efficient depectinization in fruit juice production, reducing processing time and cost.", "results_summary": "PoxaEnPG28B-Pp demonstrated superior thermostability and efficiency in depectinizing papaya, plantain, and banana juices at 65\u00b0C compared to a mesophilic enzyme, enabling simultaneous heat-treatment and depectinization.", "population_specificity": "Not applicable (in vitro enzyme study).", "effective_dosage": "Not specified (enzyme activity measured as 77882.2 U/mg with PGA substrate).", "study_duration": "15 minutes (depectinization time).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:51:53.036992+00:00"}
{"study_id": 16541, "supplement_id": 1145, "safety_score": "20", "efficacy_score": null, "quality_score": 30, "study_goal": "The researchers aimed to report a case of nephrotoxicity and neurotoxicity in a previously healthy individual after consuming concentrated star fruit juice.", "results_summary": "The study found that a man without prior kidney or neurological dysfunction developed nephrotoxicity and neurotoxicity within 12 hours of consuming concentrated star fruit juice (approximately 20 units). His renal function fully recovered after timely renal replacement therapy.", "population_specificity": "A previously healthy man without kidney or neurological dysfunction.", "effective_dosage": "Approximately 20 units of star fruit (concentrated juice).", "study_duration": "Less than 12 hours (acute toxicity).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:51:53.237472+00:00"}
{"study_id": 16542, "supplement_id": 1145, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to assess the physicochemical and sensory properties of Japanese quince fruit slices processed using osmotic pre-treatment and innovative drying methods to produce attractive dried snack foods.", "results_summary": "The study found that pre-osmotic dehydration and drying methods significantly impacted the mechanical and acoustic properties of quince chips, with hybrid drying producing sensory-attractive chips. The sensory ratings for color, taste, crispness, and flavor were high (3.8 to 4.1), and the hybrid method achieved results comparable to freeze-drying but with lower energy and time requirements.", "population_specificity": "Not specified (likely general consumers of dried fruit snacks).", "effective_dosage": "Not specified (osmotic pre-treatment used chokeberry and apple juice concentrates).", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:51:53.440752+00:00"}
{"study_id": 189115, "supplement_id": 1144, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to investigate the prevalence of idiopathic reactive hypoglycaemia (IRH) and assess the impact of dietary fibre supplementation (fructose-oligosaccharides) on glucose regulation in individuals with IRH.", "results_summary": "The study found that a 2-week fibre diet supplementation improved reactive glucose patterns during an oral glucose tolerance test (OGTT), increased late-onset glucose nadirs, reduced the frequency of hypoglycaemic episodes, and lowered fasting plasma glucose and total cholesterol levels.", "population_specificity": "Individuals with idiopathic reactive hypoglycaemia (IRH) and normal glucose tolerance, aged 56 \u00b1 8 years, BMI 25.0 \u00b1 2.9 kg/m\u00b2.", "effective_dosage": "20 g of fibre (fructose-oligosaccharides) per day.", "study_duration": "2 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:51:53.490185+00:00"}
{"study_id": 189117, "supplement_id": 1144, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to determine whether a glucose + fructose (GLU + FRC) mix in solid form (BAR) is as effectively oxidized during exercise as the same mix in liquid form (DRINK).", "results_summary": "The study found that a GLU + FRC mix in solid BAR form led to high mean and peak exogenous CHO oxidation rates, similar to the liquid DRINK form, though oxidation rates were 15% lower at certain time points. Both forms showed comparable oxidation efficiency, suggesting solid CHO can be effectively oxidized during exercise.", "population_specificity": "Eight well-trained cyclists (age 31 \u00b1 7 years, VO2max 69 \u00b1 6 mL\u00b7kg\u207b\u00b9\u00b7min\u207b\u00b9).", "effective_dosage": "1.55 g\u00b7min\u207b\u00b9 of a 2:1 glucose + fructose mix.", "study_duration": "180 minutes of cycling.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:51:54.005784+00:00"}
{"study_id": 16545, "supplement_id": 1145, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to explore the stability and inhibitory effects of potato trypsin inhibitor (PTI) derived from potato wastewater, focusing on its potential as an anti-obesity ingredient.", "results_summary": "PTI demonstrated strong inhibition (low IC50 of 6.861 \u00b1 0.107 mg/L), heat resistance, and stability across a wide pH range. It also showed resistance to gastrointestinal digestion, with limited loss of activity (29.28%) and degree of hydrolysis (24.39%).", "population_specificity": "Not specified (in vitro study)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:51:59.707697+00:00"}
{"study_id": 16548, "supplement_id": 1145, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the effectiveness of Exo-PG in improving clarity, yield, viscosity, and antioxidant properties of fruit juices (apple, mango, and peach).", "results_summary": "Exo-PG treatment significantly improved clarity, yield, and reduced viscosity in fruit juices, while also enhancing total antioxidant and phenolic content. The enzyme demonstrated stability across a wide range of temperatures and pH levels, with marked activity improvement in the presence of Mn+2.", "population_specificity": "Not specified (in vitro study on fruit juices)", "effective_dosage": "Not specified (enzyme treatment conditions described but not quantified for human consumption)", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:52:01.651903+00:00"}
{"study_id": 16547, "supplement_id": 1145, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the chemical composition, anti-inflammatory potential, and antioxidant activity of Hancornia speciosa fruit juice, as well as its effects on biochemical and hematological parameters in mice with acute pulmonary edema induced by Tityus serrulatus venom.", "results_summary": "The juice reduced edema, myeloperoxidase levels, vascular permeability, and pro-inflammatory cytokines in lung tissue, as well as oxidative stress markers in renal tissue. It also lowered serum levels of enzymes like amylase and lactate dehydrogenase, suggesting anti-inflammatory and antioxidant effects.", "population_specificity": "Mice (animal study)", "effective_dosage": "100 and 200 mg/kg (intra-gastric route)", "study_duration": "2 hours post-treatment", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:52:02.039289+00:00"}
{"study_id": 16550, "supplement_id": 1145, "safety_score": "80", "efficacy_score": 30, "quality_score": 75, "study_goal": "The researchers aimed to examine the associations between the frequency of fruit juice consumption and obesity/metabolic syndrome in Korean adults.", "results_summary": "The study found no association between fruit juice consumption and obesity, abdominal obesity, or metabolic syndrome. Whole fruit consumption, however, was linked to reduced prevalence of these conditions.", "population_specificity": "10,460 Korean adults (4,082 men and 6,378 women) aged 19-64 years.", "effective_dosage": "Frequency of consumption (rarely to daily) but no specific dosage mentioned.", "study_duration": "Cross-sectional study (data from 2012-2015).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:52:02.056029+00:00"}
{"study_id": 16546, "supplement_id": 1145, "safety_score": "85", "efficacy_score": 90, "quality_score": 80, "study_goal": "The researchers aimed to investigate the vascular effects of noni fruit juice and characterize its upstream signaling pathways, particularly its potential to reduce blood pressure.", "results_summary": "Noni juice significantly decreased blood pressure and increased nitric oxide (NO) production via endothelial nitric oxide synthase (eNOS) phosphorylation, suggesting improved endothelium-dependent relaxation. The active compound deacetylasperulosidic acid (DAA) was identified as a key contributor to these effects through the GLP-1R-induced CaMKK\u03b2-AMPK-eNOS pathway.", "population_specificity": "SHR.Cg-Leprcp/NDmcr (SHR/cp) rats, a model for hypertension.", "effective_dosage": "15 ml/kg", "study_duration": "6 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:52:02.106958+00:00"}
{"study_id": 16549, "supplement_id": 1145, "safety_score": "90", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the effects of pasteurization and storage time on the physical, chemical, and sensory quality parameters of tropical fruit juice blends with high antioxidant capacity.", "results_summary": "Pasteurization did not negatively affect functional components or sensory properties, but storage time reduced ascorbic acid content and sensory quality. Despite this, acceptability and nutritional quality remained high after 180 days of storage.", "population_specificity": "Not specified (study focused on juice formulations rather than human subjects).", "effective_dosage": "Not specified (study analyzed juice formulations, not administered dosages).", "study_duration": "180 days (storage time).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:52:02.330465+00:00"}
{"study_id": 16552, "supplement_id": 1145, "safety_score": "90", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to determine the biological effects of anthocyanin-rich fruit juice on DNA protection, antioxidant activity, body composition, and lipid metabolism in healthy males.", "results_summary": "Anthocyanin-rich fruit juice showed DNA-protective and antioxidant effects, reduced body fat, increased fat-free mass, and elevated SOD activity, but similar effects were observed with the placebo (high in vitamin C). Both beverages reduced LDL and total cholesterol.", "population_specificity": "57 healthy male volunteers", "effective_dosage": "Not specified (beverages contained >500 mg/L vitamin C)", "study_duration": "8 weeks of intervention (preceded by 1-week wash-out)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:52:02.803137+00:00"}
{"study_id": 16551, "supplement_id": 1145, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to determine the effects of pineapple fruit juice marination on pH, water holding capacity, cooking loss, color, texture, and sensory properties of spent hen meats.", "results_summary": "Increasing marination time decreased pH and water holding capacity while increasing cooking loss. Pineapple juice significantly improved meat tenderness, with 160-minute marination yielding the best results, and 80-minute marination enhancing color properties.", "population_specificity": "Spent hen meats (breast, drumstick, thigh)", "effective_dosage": "Not specified (marination times: 0, 40, 80, 120, 160 minutes)", "study_duration": "Up to 160 minutes", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:52:02.936037+00:00"}
{"study_id": 16553, "supplement_id": 1145, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the effectiveness of an immobilized enzyme (Man-AOP) in clarifying fruit juices and enhancing their reducing sugar content.", "results_summary": "The study found that Man-AOP effectively clarified apple, kiwi, orange, and peach juices while increasing their reducing sugar content. The bio-conjugate also successfully generated mannooligosaccharides (MOS) from locust bean gum over 10 cycles.", "population_specificity": "Not specified (in vitro study)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:52:07.415377+00:00"}
{"study_id": 16555, "supplement_id": 1145, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 70, "study_goal": "The researchers aimed to evaluate the effectiveness of gaseous ozone disinfection on pummelo fruit juice components, comparing filtered and unfiltered juice.", "results_summary": "Ozone treatment reduced microbial survival more effectively in filtered juice, with increased inactivation over longer treatment times. It also affected color, ascorbic acid, and phenolic content but did not activate PME activity.", "population_specificity": "Pummelo (Citrus Grandis L. Osbeck) fruit juice samples.", "effective_dosage": "Ozone concentration fixed at 600 mg/h for up to 50 minutes.", "study_duration": "Up to 50 minutes of ozone treatment.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:52:10.683835+00:00"}
{"study_id": 16557, "supplement_id": 1145, "safety_score": "80", "efficacy_score": 75, "quality_score": 70, "study_goal": "The researchers aimed to evaluate the antileishmanial activity and hydrogen peroxide induction capacity of Morinda citrifolia (noni) fruit juice against Leishmania amazonensis axenic amastigotes.", "results_summary": "Noni juice showed dose-dependent antileishmanial activity with an IC50 of 240.1 \u00b5g/mL, induced hydrogen peroxide production in peritoneal macrophages, and exhibited no cytotoxic effects or endotoxins at tested concentrations.", "population_specificity": "BALB/c peritoneal macrophages and Leishmania amazonensis-infected macrophages.", "effective_dosage": "Not specified (dose-dependent activity observed).", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:52:11.771356+00:00"}
{"study_id": 16556, "supplement_id": 1145, "safety_score": "85", "efficacy_score": 75, "quality_score": 70, "study_goal": "The researchers aimed to determine whether daily consumption of Morinda citrifolia (Noni) fruit juice (NFJ) could improve physiological parameters, particularly blood sugar levels, in patients with type 2 diabetes (DT2).", "results_summary": "NFJ consumption significantly reduced morning blood sugar levels and HbA1c values in DT2 patients. It also lowered hs-CRP in patients with high baseline levels and increased C-peptide in those with low initial levels, without causing hypoglycemia in normoglycemic patients.", "population_specificity": "Twenty patients with type 2 diabetes (DT2) undergoing standard treatment (carbohydrate-reduced diet, antidiabetic drugs, and/or insulin).", "effective_dosage": "2 ml per kg body weight per day.", "study_duration": "Eight weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:52:11.858409+00:00"}
{"study_id": 16558, "supplement_id": 1145, "safety_score": "Not Assessed", "efficacy_score": 80, "quality_score": 70, "study_goal": "The researchers aimed to determine whether blackberry (Morus nigra) fruit juice could attenuate levodopa-induced dyskinesia (LID) in a mouse model of Parkinson's disease.", "results_summary": "Blackberry fruit juice at doses of 10 and 15 mL/kg significantly reduced LID symptoms in mice, while the lower dose (5 mL/kg) showed no significant effect. The results were consistent across behavioral tests, suggesting a dose-dependent efficacy.", "population_specificity": "Male mice with MPTP-induced Parkinson's disease and levodopa-induced dyskinesia.", "effective_dosage": "5, 10, and 15 mL/kg orally, administered with levodopa.", "study_duration": "7 days of blackberry juice treatment following 2 weeks of levodopa-induced LID.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:52:12.128650+00:00"}
{"study_id": 16559, "supplement_id": 1145, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the protective effect of fresh fruit juice from Opuntia dillenii Haw. (FJOD) on acetic acid-induced ulcerative colitis in rats.", "results_summary": "FJOD significantly reduced macroscopic damage, clinical activity scores, and biochemical markers of inflammation and oxidative stress in rats with induced colitis, comparable to the effects of sulfasalazine. The protective effects were attributed to the juice's antioxidant and anti-inflammatory properties, likely due to its phenolic, flavonoid, and betalain content.", "population_specificity": "Rats with acetic acid-induced ulcerative colitis.", "effective_dosage": "2.5 and 5 ml/kg, orally for seven consecutive days.", "study_duration": "Seven days.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:52:12.313786+00:00"}
{"study_id": 16554, "supplement_id": 1145, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the effectiveness of moderate-intensity Pulsed Electric Fields (PEF) as an alternative to high-intensity PEF or thermal pasteurization for microbial inactivation in fruit juices.", "results_summary": "Moderate-intensity PEF (E = 2.7 kV/cm, \u03c4 = 15-1000 \u03bcs) was more effective than high-intensity PEF (E = 10 kV/cm, \u03c4 = 2 \u03bcs) for microbial inactivation, with effectiveness independent of pH in the range of 3.8-6.0. Non-thermal effects (electroporation) were observed under both moderate and high-intensity PEF conditions.", "population_specificity": "Microbial populations (Escherichia coli, Listeria monocytogenes, Lactobacillus plantarum, Salmonella Senftenberg, Saccharomyces cerevisiae) in orange juice, watermelon juice, and coconut water.", "effective_dosage": "Electric field strength (E) = 2.7 kV/cm, pulse width (\u03c4) = 15-1000 \u03bcs.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:52:13.577671+00:00"}
{"study_id": 16560, "supplement_id": 1145, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to investigate the effects of noni fruit juice (NFJ) on neuro-immunomodulation in lymph node lymphocytes of young and old F344 rats, focusing on immune response and intracellular signaling pathways.", "results_summary": "NFJ increased lymphocyte proliferation, cytokine production (IL-2 and IFN-\u03b3), and expression of key signaling proteins (p-ERK1/2, p-TH, p-Akt) while reducing p-NF-\u03baB in old rats, suggesting immunostimulatory effects via ERK1/2, Akt, and NF-\u03baB pathways.", "population_specificity": "Young (3-4 months) and old (16-21 months) male F344 rats.", "effective_dosage": "In vitro: 0.0001%, 0.01%, 1% NFJ; in vivo: 5%, 10%, 20% NFJ at 5 mL/kg body weight, twice daily.", "study_duration": "60 days (in vivo).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:52:14.239721+00:00"}
{"study_id": 16561, "supplement_id": 1145, "safety_score": "Not Assessed", "efficacy_score": 45, "quality_score": 75, "study_goal": "The researchers aimed to determine whether 100% fruit juice consumption was associated with long-term weight change in postmenopausal women.", "results_summary": "The study found that each 1 serving/day increase in 100% fruit juice intake was associated with a small 3-year weight gain of 0.39 lbs. The mean weight change over 3 years was 3.2 lbs.", "population_specificity": "Postmenopausal women in the United States enrolled in the Women's Health Initiative.", "effective_dosage": "1 serving/day", "study_duration": "3 years", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:52:15.336597+00:00"}
{"study_id": 16562, "supplement_id": 1145, "safety_score": "85", "efficacy_score": 50, "quality_score": 80, "study_goal": "The researchers aimed to systematically review and quantitatively summarize the effects of 100% fruit juice on glucose-insulin homeostasis through randomized controlled trials.", "results_summary": "The meta-analysis found no significant effect of 100% fruit juice on fasting blood glucose, fasting blood insulin, HOMA-IR, or HbA1c, suggesting a neutral impact on glycaemic control. These results align with observational studies indicating no increased diabetes risk from 100% fruit juice consumption.", "population_specificity": "Not specified (meta-analysis of 18 RCTs)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:52:19.324560+00:00"}
{"study_id": 16566, "supplement_id": 1145, "safety_score": "85", "efficacy_score": 90, "quality_score": 80, "study_goal": "The researchers aimed to determine the effect of fruit and vegetable (FV) juice on oxidative damage biomarkers and antioxidant gene expression in rats.", "results_summary": "FV juice increased antioxidant capacity, glutathione, vitamin C, \u03b2-carotene, polyphenols, flavonoids, and glutathione peroxidase activity while reducing malondialdehyde levels. It also significantly modulated antioxidant gene expression in the liver and brain.", "population_specificity": "Adult male Wistar rats", "effective_dosage": "Low and high FV juice dosage (specific amounts not provided)", "study_duration": "5 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:52:20.143666+00:00"}
{"study_id": 16563, "supplement_id": 1145, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to investigate the phytochemical composition, antioxidant activity, and effects of Momordica charantia fruit and leafy stem juices on human T cell proliferation and differentiation, particularly their potential antidiabetic and immunomodulatory properties.", "results_summary": "Total fruit and leafy stem juices induced T cell proliferation and enhanced immune responses, while filtered versions inhibited PHA-stimulated T cell proliferation and showed immunosuppressive effects. The study also identified key phytochemicals and noted appreciable antioxidant capacity in both juices.", "population_specificity": "Human T cells (in vitro study)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:52:20.244283+00:00"}
{"study_id": 16564, "supplement_id": 1145, "safety_score": "85", "efficacy_score": 78, "quality_score": 82, "study_goal": "The researchers aimed to determine whether Baccaurea angulata (BA) fruit juice could improve hematological and biochemical biomarkers in normo- and hypercholesterolemic rabbits.", "results_summary": "BA juice significantly ameliorated diet-induced alterations in hematological and biochemical biomarkers, with dose-dependent improvements, particularly at the highest dose (1.5mL/kg/day). The results suggest potential benefits against hypercholesterolemia-associated changes.", "population_specificity": "Healthy adult New Zealand White rabbits (35 total).", "effective_dosage": "0.5, 1.0, and 1.5mL/kg/day for hypercholesterolemic groups; 0.5 and 1.0mL/kg/day for normal groups.", "study_duration": "90 days.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:52:22.688047+00:00"}
{"study_id": 16565, "supplement_id": 1145, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to evaluate the effectiveness of pectinolytic enzymes (PG, PL, PME) isolated from *Aspergillus ornatus* for clarifying fruit juices (apple, mango, peach, apricot).", "results_summary": "The study found that chitosan-immobilized pectinolytic enzymes (CTS-PG, CTS-PME, CTS-PL) significantly reduced color and turbidity in fruit juices, with CTS-PG showing the highest efficacy. Immobilization improved pH and thermal stability without compromising enzyme flexibility.", "population_specificity": "Not specified (in vitro study on fruit juice samples).", "effective_dosage": "Not specified (enzyme activity measured as 475.2U/mg for PG, 557.1U/mg for PL, 205.7U/mg for PME).", "study_duration": "60-minute treatment for juice clarification.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:52:23.006786+00:00"}
{"study_id": 16567, "supplement_id": 1145, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 75, "study_goal": "The researchers aimed to investigate the effects of noni fruit juice (NFJ) on intestinal inflammation in mice exposed to dextran sulfate sodium (DSS).", "results_summary": "NFJ preserved intestinal architecture and reduced inflammatory markers (TNF-\u03b1, IFN-\u03b3, nitric oxide, IL-17) but did not alleviate clinical signs or weight loss. The effects were concentration-dependent, with 1:10 and 1:100 dilutions showing the most benefit.", "population_specificity": "C57BL/6 mice with DSS-induced intestinal inflammation.", "effective_dosage": "Dilutions of 1:10 and 1:100 (specific volume/frequency not stated).", "study_duration": "9 consecutive days.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:52:23.094040+00:00"}
{"study_id": 16569, "supplement_id": 1145, "safety_score": "Not Assessed", "efficacy_score": 90, "quality_score": 85, "study_goal": "The researchers aimed to investigate the antidiabetic and antioxidant effects of Momordica charantia (bitter gourd) fruit juice in streptozotocin-induced type 2 diabetic rats.", "results_summary": "The study found that Momordica charantia juice significantly reduced serum glucose, fructosamine, cholesterol, triglycerides, insulin resistance, and pancreatic oxidative stress while increasing insulin levels, HDL-cholesterol, antioxidant capacity, and \u03b2-cell function. It also improved glucose uptake in muscle tissue and pancreatic histopathology.", "population_specificity": "Male Wistar rats with streptozotocin-induced type 2 diabetes.", "effective_dosage": "10 mL/kg/day orally.", "study_duration": "14 days prophylaxis + 21 days treatment or 21 days treatment alone.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:52:25.111640+00:00"}
{"study_id": 16568, "supplement_id": 1145, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to investigate the effects of Morinda citrifolia fruit juice (NFJ) on neural-immune interactions and intracellular signaling pathways in young and old male F344 rats.", "results_summary": "NFJ enhanced immune responses (lymphocyte proliferation, IL-2, IFN-\u03b3 production) and cell survival pathways (p-ERK, p-Akt, p-CREB) while suppressing inflammatory markers (IL-6, lipid peroxidation, NF-\u03baB) in both in vitro and in vivo studies.", "population_specificity": "Young and old male F344 rats.", "effective_dosage": "In vitro: 0.0001-1% NFJ for 24h; in vivo: 5%, 10%, 20% NFJ (5ml/kg body weight) twice daily.", "study_duration": "60 days (in vivo).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:52:25.604646+00:00"}
{"study_id": 16570, "supplement_id": 1145, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the effectiveness of immobilized exo-polygalacturonase (exo-PG) in improving the clarity, viscosity, and turbidity of various fruit juices.", "results_summary": "Immobilized exo-PG derivatives showed enhanced thermal stability, catalytic activity, and recycling efficiency, significantly improving fruit juice clarity and reducing viscosity and turbidity. Covalent immobilization was more effective than adsorption, with retained activity after multiple uses.", "population_specificity": "Not specified (in vitro study on fruit juices)", "effective_dosage": "Not specified", "study_duration": "Not specified (multiple batch reactions assessed)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:52:27.860460+00:00"}
{"study_id": 16572, "supplement_id": 1145, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the effects of alternative nonthermal technologies on the nutritional, physicochemical, and sensory qualities of fruit juices compared to traditional thermal treatments.", "results_summary": "The study found that nonthermal alternatives (e.g., UV light, high hydrostatic pressure) are generally less detrimental to juice quality than thermal methods, but outcomes vary based on processing parameters and juice type. Future research should focus on scaling up these technologies while preserving juice attributes.", "population_specificity": "Not specified (general fruit juice processing)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:52:28.957745+00:00"}
{"study_id": 16571, "supplement_id": 1145, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to investigate the anticraving effect of Tahitian Noni Juice (TNJ) against ethanol-seeking behavior in mice using the conditioned place preference (CPP) test.", "results_summary": "TNJ-treated mice showed a significant reduction in ethanol-seeking behavior in the CPP test, comparable to the reference drug acamprosate. The study suggests TNJ could be effective in attenuating ethanol craving and potentially useful for treating alcohol dependence.", "population_specificity": "ICR male mice", "effective_dosage": "TNJ was provided as a source of drinking water (specific concentration not stated)", "study_duration": "12 days of conditioning, 12 days of extinction, plus reinstatement phase", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:52:29.621339+00:00"}
{"study_id": 16573, "supplement_id": 1145, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the associations between 100% fruit juice intake and markers of antioxidant/oxidant status and blood lipid levels in healthy adults.", "results_summary": "Limited evidence suggests potential improvements in antioxidant or oxidant biomarkers after consuming 100% fruit juice, while weak evidence indicates possible positive effects on blood lipid measures. However, methodological heterogeneity prevents definitive conclusions on dose-duration-juice effects.", "population_specificity": "Healthy, free-living adults aged 18 years or older.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:52:30.813356+00:00"}
{"study_id": 16575, "supplement_id": 1145, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to develop a magnetic tri-enzyme nanobiocatalyst for improving fruit juice clarification by breaking down polysaccharides like cellulose, pectin, and starch.", "results_summary": "The nanobiocatalyst showed enhanced thermal and pH stability, retained 75% residual activity after eight reuse cycles, and reduced turbidity in apple, grape, and pineapple juices by 41%, 46%, and 53%, respectively, after 150 minutes of treatment.", "population_specificity": "Not specified (in vitro study)", "effective_dosage": "Not specified", "study_duration": "150 minutes (treatment time)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:52:31.384787+00:00"}
{"study_id": 16574, "supplement_id": 1145, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether underwater shockwave pretreatment enhances the functional and antioxidant properties of yuzu juice compared to traditional squeezing methods.", "results_summary": "Underwater shockwave pretreatment at 3.5kV and 4.9kJ increased flavanone glycoside content and ORAC values, with the ORAC value rising approximately 1.7 times in yuzu juice from Rikuzentakata. The method showed reliable performance for extracting functional and antioxidant compounds, comparable to traditional squeezing.", "population_specificity": "Yuzu juice (no specific human population studied).", "effective_dosage": "Not specified (pretreatment parameters: 3.5kV discharge, 4.9kJ energy).", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:52:32.729420+00:00"}
{"study_id": 16576, "supplement_id": 1145, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to develop a method for determining naringenin enantiomers in fruit juices using SALLE and HPLC-DAD.", "results_summary": "The study successfully developed an efficient method for extracting and analyzing naringenin enantiomers in fruit juices, achieving high recovery rates (85.6\u201397.1%) and validating the method for various juice samples.", "population_specificity": "Not specified (fruit juice samples analyzed in vitro).", "effective_dosage": "Not applicable (analytical method study).", "study_duration": "Not applicable (analytical method study).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:52:33.879429+00:00"}
{"study_id": 16577, "supplement_id": 1145, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the technological characteristics and bioactive compounds of juice from Opuntia dillenii cactus fruits and assess the impact of pulsed electric fields (PEF) compared to microwave heating and pectinases on juice yield and quality.", "results_summary": "The cactus juice exhibited desirable technological characteristics and high phenolic content, contributing to antioxidant activity. PEF treatment increased juice yield and improved characteristics, with maximal release of isorhamnetin 3-O-rutinoside from the peel into the juice.", "population_specificity": "Not specified (study focused on fruit mash and juice characteristics).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:52:34.979165+00:00"}
{"study_id": 16578, "supplement_id": 1145, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 70, "study_goal": "The researchers aimed to evaluate the effects of Noni fruit juice on serum lipid profile in a high-fat diet-induced murine model of dyslipidemia.", "results_summary": "Noni fruit juice significantly reduced total cholesterol, triglycerides, and very low-density lipoprotein cholesterol at both tested doses compared to the disease control. However, the reduction in TC and LDL-C levels at the 50mg/kg dose was not statistically significant compared to Atorvastatin.", "population_specificity": "Wistar albino rats of either sex (n=8) with high-fat diet-induced dyslipidemia.", "effective_dosage": "50mg/kg/day and 100mg/kg/day, per oral.", "study_duration": "30 days.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:52:37.191617+00:00"}
{"study_id": 16579, "supplement_id": 1145, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to uncover the molecular pathway underlying the anti-cancer efficacy of Taiwan pomegranate fruit juice against urinary bladder urothelial carcinoma.", "results_summary": "The study found that ethanol extract from pomegranate juice altered the expression of 20 proteins involved in apoptosis, cytoskeleton regulation, and cell proliferation, suggesting inhibition of cancer cell growth via the PTEN/AKT/mTORC1 pathway and apoptosis induction through Diablo over-expression.", "population_specificity": "Urinary bladder urothelial carcinoma cells (T24 cell line)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:52:37.206857+00:00"}
{"study_id": 16580, "supplement_id": 1145, "safety_score": "90", "efficacy_score": 80, "quality_score": 85, "study_goal": "The researchers aimed to assess the efficacy and safety of Citron syrup (containing Citrus medica L. fruit juice) in reducing migraine headache symptoms compared to placebo and propranolol.", "results_summary": "Citron syrup significantly reduced headache intensity and duration compared to placebo and was as effective as propranolol, but it did not significantly reduce attack frequency. No serious side effects were observed.", "population_specificity": "Ninety patients with migraine headache.", "effective_dosage": "15ml of Citron syrup three times daily after meals.", "study_duration": "4 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:52:37.620621+00:00"}
{"study_id": 16582, "supplement_id": 1145, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to investigate the antibacterial activity of Citrus limonum fruit juice extract against various bacterial strains.", "results_summary": "The extract showed bacteriostatic and bactericidal effects against multiple bacterial strains, including Bacillus subtilis, Staphylococcus aureus, Escherichia coli, and others, with MICs ranging from 0.78 mg/ml to 50 mg/ml and MBCs from 25.0 mg/ml to >100 mg/ml. The results support its traditional medicinal use for bacterial infections.", "population_specificity": "Bacterial strains (both standard ATCC strains and locally isolated clinical strains).", "effective_dosage": "MICs (0.78\u201350 mg/ml), MBCs (25.0\u2013>100 mg/ml).", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:52:40.403255+00:00"}
{"study_id": 16583, "supplement_id": 1145, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to investigate changes in phenolic compounds in two Malaysian pummelo fruit juice varieties (Ledang and Tambun) post-enzymatic clarification and assess their impact on juice quality and bitterness.", "results_summary": "The study found that Tambun variety had significantly higher total phenolic compounds than Ledang, with naringin and chlorogenic acid being major contributors. Enzymatic treatment reduced naringin (reducing bitterness) without significantly affecting total phenolic content.", "population_specificity": "Malaysian pummelo fruit juice varieties (Ledang and Tambun).", "effective_dosage": "Not specified (optimized enzyme concentration, temperature, and time used).", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:52:41.566667+00:00"}
{"study_id": 16584, "supplement_id": 1145, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to develop a predictive model for ascorbic acid degradation in heated simulated fruit juices based on product and process parameters.", "results_summary": "The study found that temperature and heating time significantly affected ascorbic acid reduction, with validation systems showing acceptable predictive efficacy (bias factors 0.80-1.20, accuracy factor 1.00-1.26). The model may help optimize process schedules for food safety and quality.", "population_specificity": "Simulated fruit juices (not human or animal subjects).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:52:42.072509+00:00"}
{"study_id": 16581, "supplement_id": 1145, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to evaluate how food matrix (fruit juice blended with water, milk, or soymilk) and processing methods (HIPEF, HPP, TT) influence carotenoid bioaccessibility and lipophilic antioxidant activity in beverages.", "results_summary": "Carotenoid bioaccessibility generally decreased after processing (except for cis-violaxanthin + neoxanthin, which increased by 79% with HIPEF and HPP). Milk-based beverages (MB) showed the highest carotenoid bioaccessibility and lipophilic antioxidant activity, while thermal treatment (TT) resulted in the lowest bioaccessibility (losses up to 63%). HIPEF and HPP were identified as promising technologies for producing nutritious and functional beverages.", "population_specificity": "Not specified (in vitro or model system implied).", "effective_dosage": "Not specified (processing conditions: HIPEF\u201435 kV cm\u207b\u00b9, 4 \u03bcs bipolar pulses at 200 Hz for 1800 \u03bcs; HPP\u2014400 MPa at 40 \u00b0C for 5 min; TT\u201490 \u00b0C for 1 min).", "study_duration": "Single processing event (no longitudinal intervention).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:52:43.858518+00:00"}
{"study_id": 16585, "supplement_id": 1145, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to investigate how simulated processing (pH adjustment and thermal treatment) affects the antioxidant capacity and in vitro protein digestion of fruit juice-milk beverage models containing whey protein and phenolic compounds (chlorogenic acid or catechin).", "results_summary": "The study found that catechin was more susceptible to processing than chlorogenic acid, with significant decreases in antioxidant capacity after sterilization. Whey protein addition had varying effects on antioxidant activity, while sterilization significantly altered antioxidant measures depending on the model. In vitro digestion of whey protein was inhibited by phenolics but minimally affected by pasteurization.", "population_specificity": "Not specified (in vitro study)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:52:44.236395+00:00"}
{"study_id": 16586, "supplement_id": 1145, "safety_score": "90", "efficacy_score": 30, "quality_score": 75, "study_goal": "The researchers aimed to determine whether Boysenberry juice, apple fiber, or their combination had a greater benefit on gut health compared to a placebo.", "results_summary": "The study found no significant differences in gut health measures (bacterial levels, short-chain fatty acids) between the Boysenberry juice, apple fiber, combination beverage, and placebo, except for higher prostaglandin E2 concentrations after Boysenberry juice consumption.", "population_specificity": "25 individuals (specific demographics not detailed).", "effective_dosage": "350 g daily (175 mL twice daily).", "study_duration": "4 weeks per treatment phase.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:52:45.317441+00:00"}
{"study_id": 16587, "supplement_id": 1145, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 70, "study_goal": "The researchers aimed to determine the effect of Aronia melanocarpa fruit juice on memory in male Wistar rats.", "results_summary": "The study found that Aronia melanocarpa fruit juice, when administered for 21 and 30 days, significantly improved memory in rats, as evidenced by prolonged latency times and increased learning criterion at higher doses (5 ml/kg and 10 ml/kg). Shorter durations (7 and 14 days) showed a dose-dependent trend but lacked statistical significance.", "population_specificity": "Male Wistar rats", "effective_dosage": "2.5 ml/kg, 5 ml/kg, and 10 ml/kg administered orally", "study_duration": "7, 14, 21, and 30 days", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:52:46.921803+00:00"}
{"study_id": 16588, "supplement_id": 1145, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine the chemopreventive effects of pomegranate fruit juice (PFJ) and its component ellagic acid (EA) on prostate cancer development and progression using in vivo and in vitro models.", "results_summary": "PFJ reduced adenocarcinoma incidence in the lateral prostate, while both PFJ and EA suppressed prostate carcinogenesis progression and induced apoptosis via caspase 3 activation. EA also decreased lipid peroxidation and inhibited proliferation in androgen-dependent prostate cancer cells (LNCaP) but not in androgen-independent cells (PC-3, DU145).", "population_specificity": "Transgenic rats for adenocarcinoma of prostate (TRAP) and human prostate cancer cell lines (LNCaP, PC-3, DU145).", "effective_dosage": "Not specified", "study_duration": "10 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:52:48.641729+00:00"}
{"study_id": 16589, "supplement_id": 1145, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers evaluated the operational stability and cost-benefit of anaerobic co-digestion of organic waste streams, including those from a fruit-juice/winery wastewater treatment plant, with municipal sludge and landfill leachate.", "results_summary": "Co-digestion improved operational stability and dewaterability of digested streams, with thermophilic digesters producing Class A biosolids. A cost-benefit analysis showed a 22% reduction in capital and operational costs for full-scale co-digestion.", "population_specificity": "Organic waste streams from a fruit-juice/winery wastewater treatment plant, municipal sludge, and landfill leachate.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:52:50.429821+00:00"}
{"study_id": 16591, "supplement_id": 1145, "safety_score": "85", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the safety and potential toxic effects of Annona muricata Linn. fruit juice in rats following acute and subchronic oral administration.", "results_summary": "The study found no significant toxic effects at doses up to 2000 mg/kg, though temporary reductions in platelet count and packed cell volume were observed at higher doses. AM also increased sperm count, motility, and antioxidant levels in the liver and kidney, but elevated malondialdehyde and reduced SOD activity in the brain at the highest dose.", "population_specificity": "Sprague-Dawley rats", "effective_dosage": "80, 400, and 2000 mg/kg orally daily", "study_duration": "60 days", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:52:50.972825+00:00"}
{"study_id": 16592, "supplement_id": 1145, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to develop and optimize an eugenol-loaded nanoemulsion using sesame oil and assess its antibacterial efficacy, particularly in orange juice.", "results_summary": "The optimized eugenol-loaded nanoemulsion (S3E3) demonstrated reduced droplet size, enhanced stability, and significant antibacterial activity against Staphylococcus aureus, including altering membrane permeability and reducing native bacteria in orange juice.", "population_specificity": "Not specified (in vitro study on bacteria and orange juice)", "effective_dosage": "Not specified (oil-surfactant mixing ratio of 1:3 v/v used)", "study_duration": "Stability tested for >1 month; antibacterial effects assessed in situ", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:52:52.939462+00:00"}
{"study_id": 16593, "supplement_id": 1145, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to investigate the antioxidant and antiproliferative properties of patatin purified from potato fruit juice, particularly against mouse melanoma B16 cells.", "results_summary": "Patatin demonstrated significant antioxidant activity, including scavenging free radicals, reducing power, and protecting against oxidative DNA damage and lipid peroxidation. It also showed potent antiproliferative effects on B16 cells, inducing cell cycle arrest and apoptosis at 20 mg/mL.", "population_specificity": "Mouse melanoma B16 cells (in vitro study).", "effective_dosage": "20 mg/mL (single concentration tested).", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:52:53.150780+00:00"}
{"study_id": 16594, "supplement_id": 1145, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to compare four sample preparation procedures for determining trace element concentrations in fruit juices using ICP OES.", "results_summary": "The study found that dilution with 2% HNO3 and centrifugation (P2) provided the best results in terms of precision, accuracy, and detection limits, making it suitable for routine analysis. Element concentrations matched those from wet digestion, validating P2 as a simpler alternative.", "population_specificity": "Commercial fruit juices (no human subjects studied).", "effective_dosage": "Not applicable (sample preparation methods compared).", "study_duration": "Not applicable (laboratory analysis, no intervention period).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:52:55.778579+00:00"}
{"study_id": 16595, "supplement_id": 1145, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the protective effects of commercial noni juice (TNJ) against genotoxic lesions induced by mitomycin C (MMC) and doxorubicin (DXR) in Drosophila melanogaster.", "results_summary": "TNJ reduced genotoxic effects of MMC and DXR, showing a marked decrease in mutant spots, primarily due to its antirecombinagenic activity. The protective effects were concentration-dependent, suggesting antioxidant and free radical scavenging properties.", "population_specificity": "Drosophila melanogaster larvae (trans-heterozygous for genetic markers mwh and flr3).", "effective_dosage": "Not specified (concentration-dependent effects noted).", "study_duration": "Not specified (three-day-old larvae were used).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:52:56.211323+00:00"}
{"study_id": 16596, "supplement_id": 1145, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether the antioxidant effects of a high fruit-juice and vegetable diet vary based on GSTM1/GSTT1 genotypes.", "results_summary": "The study found that a high fruit-juice and vegetable diet increased antioxidant capacity and enzyme activities, with stronger and faster effects in participants with GSTM1+/GSTT1+ genotypes compared to those with GSTM1-/GSTT1- genotypes.", "population_specificity": "24 healthy volunteers with different GST genotypes (12 GSTM1+/GSTT1+ and 12 GSTM1-/GSTT1-).", "effective_dosage": "Not specified (controlled diet high in fruit-juice and vegetables).", "study_duration": "2 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:52:58.231151+00:00"}
{"study_id": 16598, "supplement_id": 1145, "safety_score": "80", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to investigate the hepatoprotective effects of prickly pear juice (PPJ) against ethanol-induced liver injury in rats.", "results_summary": "PPJ significantly reduced liver lipid and protein oxidation, histopathologic lesions, and restored antioxidant enzyme activities while lowering liver injury markers in ethanol-fed rats. The hepatoprotective effect may be due to PPJ's ability to scavenge free radicals or enhance endogenous antioxidants.", "population_specificity": "Wistar rats with ethanol-induced liver injury.", "effective_dosage": "20 and 40 ml/kg body weight, orally.", "study_duration": "90 days.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:52:59.324551+00:00"}
{"study_id": 16597, "supplement_id": 1145, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to validate the accuracy of self-reported fruit, juice, and vegetable (FJV) intake in children using WebDASC by comparing it with plasma carotenoid concentrations and photographic observations of actual consumption.", "results_summary": "Self-reported FJV intake, particularly fruit and juice, showed significant correlations with plasma carotenoid concentrations (0.58 overall, 0.38 for fruit, 0.42 for juice). WebDASC achieved 82% reporting matches overall, with higher accuracy for fruits compared to beverages.", "population_specificity": "8- to 11-year-old Danish children.", "effective_dosage": "Not specified.", "study_duration": "7 consecutive days of dietary reporting, with 5 schooldays of photographic observation.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:53:00.134268+00:00"}
{"study_id": 16600, "supplement_id": 1145, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to assess the performance of a combined anaerobic hybrid reactor and sequencing batch reactor system for treating wastewater from the fruit-juice industry.", "results_summary": "The study found that a two-stage anaerobic hybrid reactor system followed by a sequencing batch reactor significantly improved the removal efficiency of COD, BOD5, VFA, and TSS from fruit-juice industry wastewater, achieving nearly complete removal of BOD5 and oil and grease in the final effluent.", "population_specificity": "Fruit-juice industry wastewater", "effective_dosage": "Not applicable (wastewater treatment study)", "study_duration": "Not specified (three experimental runs conducted)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:53:01.494295+00:00"}
{"study_id": 16599, "supplement_id": 1145, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the effectiveness of combining aerobic biological treatment with chemical coagulation/flocculation for treating high-concentration fruit juice wastewater.", "results_summary": "The study found that aerobic biological treatment achieved over 90% COD removal, with the Haldane-inhibition model best fitting the biodegradation. A tertiary coagulation/flocculation process further improved efficiency, achieving 94.4% turbidity and 99.6% COD removal using ferric chloride at optimal conditions.", "population_specificity": "Fruit juice wastewater (not human subjects).", "effective_dosage": "0.44 g L(-1) of ferric chloride coagulant at pH = 5.5.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:53:01.584518+00:00"}
{"study_id": 16590, "supplement_id": 1145, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the anti-inflammatory and antioxidant effects of Feijoa sellowiana fruit juice in vivo and in vitro.", "results_summary": "The fruit juice demonstrated significant anti-inflammatory activity, reducing edema by 44.11-44.12% over five hours, and effectively inhibited superoxide anion release in human whole blood, particularly at concentrations of 10(-4) and 10(-2) mg/mL. The effects were linked to interaction with the protein-kinase C pathway.", "population_specificity": "Human whole blood (in vitro) and carrageenin-induced paw edema test (in vivo, likely animal model).", "effective_dosage": "10(-4) and 10(-2) mg/mL (in vitro).", "study_duration": "Up to five hours (in vivo).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:53:02.063086+00:00"}
{"study_id": 16601, "supplement_id": 1145, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the cardioprotective effects of Lagenaria siceraria fruit juice in rats with isoproterenol-induced myocardial infarction.", "results_summary": "The study found that L. siceraria fruit juice significantly mitigated biochemical and histopathologic changes caused by isoproterenol, suggesting cardioprotective effects. It restored altered levels of serum proteins, ions, and enzyme activities while reducing myocardial damage.", "population_specificity": "Rats with induced myocardial infarction", "effective_dosage": "400 mg/kg/day, orally", "study_duration": "30 days", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:53:04.460590+00:00"}
{"study_id": 16602, "supplement_id": 1145, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to determine whether a Fruit Juice Drink (FJD) composed of pineapple, blackcurrant, and plum could modulate IL-17 production in response to a High Fat Meal (HFM) in healthy overweight humans.", "results_summary": "The study found that the Fruit Juice Drink significantly inhibited the IL-17 inflammatory response induced by the High Fat Meal, demonstrating a marked reduction in IL-17 levels compared to the placebo. The effect was statistically significant (ANOVA between treatment p=0.037).", "population_specificity": "Fourteen healthy overweight humans.", "effective_dosage": "Not specified (test meal provided 1344 Kcal).", "study_duration": "Single intervention with measurements taken up to 8 hours post-consumption.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:53:05.666065+00:00"}
{"study_id": 16603, "supplement_id": 1145, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether noni fruit juice (NFJ) could inhibit manganese-induced HIF-1\u03b1 protein expression in human lung carcinoma cells, potentially suggesting beneficial effects on lung pathologies.", "results_summary": "NFJ inhibited manganese-induced HIF-1\u03b1 protein upregulation in a concentration-dependent manner, likely by interfering with manganese's signaling pathways (PKB, ERK-1/2, JNK-1, and S6). NFJ also repressed HIF-1\u03b1 induction by other inducers like desferoxamine and IL-1\u03b2.", "population_specificity": "A549 human lung carcinoma cells (in vitro study).", "effective_dosage": "Concentration-dependent (specific amounts not provided).", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:53:07.873601+00:00"}
{"study_id": 16604, "supplement_id": 1145, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to compare the effects of high-intensity pulsed electric fields (HIPEF) and thermal treatments on phenolic and carotenoid compounds in a fruit juice-soymilk beverage during storage.", "results_summary": "HIPEF and thermal treatments increased hesperidin and total phenolic concentrations initially but reduced carotenoid levels. Over time, some phenolics and carotenoids increased, while others decreased or remained stable. HIPEF-treated beverages showed fewer changes than heat-processed ones, suggesting better preservation of antioxidant profiles.", "population_specificity": "Not specified (beverage analysis, not human subjects)", "effective_dosage": "HIPEF (35kV/cm, 4\u03bcs bipolar pulses at 200Hz for 800 or 1400\u03bcs) or thermal (90\u00b0C, 60s)", "study_duration": "Storage at 4\u00b0C (duration not specified)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:53:09.631508+00:00"}
{"study_id": 16605, "supplement_id": 1145, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to compare the effects of high-intensity pulsed electric fields (HIPEF) and thermal processing on water-soluble vitamins, antioxidant capacity, enzyme inactivation, and color stability in beverages containing fruit juices and milk.", "results_summary": "HIPEF-treated beverages retained high vitamin C and B vitamins, maintained antioxidant capacity, and preserved color better than thermally treated beverages, though vitamin C declined during storage. Thermal processing was more effective at inactivating enzymes (POD and LOX) but reduced riboflavin levels.", "population_specificity": "Not specified (beverages containing fruit juices and milk were studied, not human subjects).", "effective_dosage": "Not specified (processing methods were compared, not dosages).", "study_duration": "Refrigerated storage duration not explicitly stated.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:53:10.133733+00:00"}
{"study_id": 16606, "supplement_id": 1145, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to develop a method for detecting diethofencarb and pyrimethanil residues in water and fruit juice samples.", "results_summary": "The study successfully developed an efficient extraction method with high enrichment factors (265 and 253 for diethofencarb and pyrimethanil, respectively) and low detection limits (0.01 \u03bcg L(-1)). The method demonstrated good linearity (0.05-2000 \u03bcg L(-1)) and high recovery rates (86-117%) in fruit juice samples.", "population_specificity": "Not specified (focus on analytical method development).", "effective_dosage": "Not applicable (analytical method study).", "study_duration": "Not applicable (analytical method study).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:53:11.097943+00:00"}
{"study_id": 65796, "supplement_id": 1145, "safety_score": "Not Assessed", "efficacy_score": 30, "quality_score": 75, "study_goal": "The researchers aimed to compare the effects of fruit juice against other beverages, particularly low/no-calorie sweetened beverages, on weight loss in adults.", "results_summary": "The study found that low/no-calorie sweetened beverages were more effective for weight loss compared to fruit juice, with a mean difference of -0.83 kg. However, the certainty of evidence was rated low, and no significant effect was seen in trials with low risk of bias or calorie restriction.", "population_specificity": "Adults (4168 participants across 78 randomized trials)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:53:11.535837+00:00"}
{"study_id": 16607, "supplement_id": 1145, "safety_score": "85", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to study the association between 100% fruit juice intake and the risk of obesity and metabolic syndrome in a representative sample of the U.S. population.", "results_summary": "Consumers of 100% fruit juice had lower mean BMI, waist circumference, and insulin resistance compared to nonconsumers, with a 22% lower odds of obesity and 15% lower odds of metabolic syndrome. The association with metabolic syndrome was explained by other lifestyle factors, while the obesity association remained independent.", "population_specificity": "Multiethnic sample of U.S. adults from the National Health and Nutrition Examination Survey 1999-2004.", "effective_dosage": "Not specified (oz/d categories analyzed but exact amounts not provided).", "study_duration": "Cross-sectional analysis (no specific intervention duration).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:53:13.073537+00:00"}
{"study_id": 65797, "supplement_id": 1145, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the potential of vitamin D fortification in food items, including fruit juice, to address deficiency in children.", "results_summary": "The study found that vitamin D fortification of food items like fruit juice is a viable strategy to combat deficiency, with oral supplementation being well-tolerated and effective. Fortification of commonly consumed items was highlighted as an ideal approach.", "population_specificity": "Indian children with vitamin D deficiency/insufficiency.", "effective_dosage": "1200-10,000 IU/d (oral vitamin D supplementation mentioned, but not specific to fruit juice).", "study_duration": "Not specified for fruit juice fortification.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:53:14.164031+00:00"}
{"study_id": 65798, "supplement_id": 1145, "safety_score": "Not Assessed", "efficacy_score": 50, "quality_score": 75, "study_goal": "The researchers aimed to evaluate changes in dietary habits, including fruit juice consumption, during the transition from primary to secondary school.", "results_summary": "The study found inconsistent results regarding changes in the frequency of fruit juice consumption across the school transition, with no clear trend identified.", "population_specificity": "Children transitioning from primary to secondary school.", "effective_dosage": "Not specified", "study_duration": "Longitudinal assessment with follow-up during the first or second year of secondary school.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:53:14.396977+00:00"}
{"study_id": 65799, "supplement_id": 1145, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to determine whether nudges (including promoting 100% fruit juice as a swap for sugary drinks) could reduce sugary drink purchases by caregivers in lower-income households.", "results_summary": "The study found that nudges, including offering 100% fruit juice as a swap, significantly reduced calories, total sugar, and added sugar from sugary drinks purchased for children.", "population_specificity": "Caregivers with lower-income households and children aged 1-5 years.", "effective_dosage": "Not specified", "study_duration": "Single shopping experiment session", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:53:16.472502+00:00"}
{"study_id": 65802, "supplement_id": 1145, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to provide evidence-based recommendations for treating hypoglycemia, including the use of fruit juice as a source of glucose.", "results_summary": "The study found that fruit juice, along with other carbohydrate sources containing glucose, can be used to treat hypoglycemia in conscious individuals with blood glucose <70 mg/dL, particularly in pediatric patients using advanced insulin delivery systems.", "population_specificity": "Pediatric patients with diabetes, especially those using continuous glucose monitoring (CGM) or advanced hybrid closed-loop systems.", "effective_dosage": "Not specified for fruit juice; general recommendation is 0.3 g/kg oral glucose (0.1 g/kg for children using advanced insulin delivery systems).", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:53:19.116485+00:00"}
{"study_id": 65800, "supplement_id": 1145, "safety_score": "Not Assessed", "efficacy_score": 30, "quality_score": 65, "study_goal": "The researchers aimed to compare the microleakage of fiber-reinforced glass ionomer cement and conventional glass ionomer cement restorations when exposed to different beverages, including fresh fruit juice.", "results_summary": "The study found that fresh fruit juice caused significant microleakage in fiber-reinforced glass ionomer cement under high immersion conditions. Conventional glass ionomer cement showed the highest microleakage with soft drinks, but fresh fruit juice also contributed to microleakage in intergroup comparisons.", "population_specificity": "Human exfoliating deciduous molars (pediatric dental context).", "effective_dosage": "Not specified (immersion regimes described but not quantified).", "study_duration": "Not specified (immersion duration not detailed).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:53:19.520146+00:00"}
{"study_id": 65807, "supplement_id": 1145, "safety_score": "Not Assessed", "efficacy_score": 20, "quality_score": 85, "study_goal": "The researchers aimed to explore the relationship between dietary composition, including prepacked fruit juice, and inflammation in adult eosinophilic esophagitis (EoE) patients.", "results_summary": "The study found that prepacked fruit juice was significantly positively (unfavorably) related to peak eosinophil count (PEC), indicating it may exacerbate inflammation in EoE patients. No favorable effects of fruit juice were reported.", "population_specificity": "39 Dutch adult patients with eosinophilic esophagitis (EoE).", "effective_dosage": "Not specified", "study_duration": "6 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:53:19.975544+00:00"}
{"study_id": 65804, "supplement_id": 1145, "safety_score": "90", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to comprehensively review the anti-oxidative and anti-inflammatory effects of pomegranate and its derivatives in managing chronic disorders based on in-vitro, in-vivo, and clinical studies.", "results_summary": "Pomegranate and its derivatives modulate oxidative stress and inflammation pathways, demonstrating preventive and therapeutic effects against cardiovascular diseases, diabetes, neurological diseases, and cancers without serious adverse effects. Bioactive compounds in various parts of the pomegranate contribute to these benefits.", "population_specificity": "Not specified (in-vitro, in-vivo, and clinical studies reviewed).", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:53:20.540166+00:00"}
{"study_id": 65808, "supplement_id": 1145, "safety_score": "80", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to review the anticancer and chemopreventive potential of Noni fruit juice and its bioactive compounds through in vitro, in vivo, and clinical studies.", "results_summary": "The compiled studies demonstrated Noni's multifaceted anticancer effects, including apoptosis induction, cell cycle arrest, antiangiogenesis, and immune modulation, supporting its potential in cancer prevention and treatment.", "population_specificity": "Not specified (review of existing studies).", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:53:21.023127+00:00"}
{"study_id": 65809, "supplement_id": 1145, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 65, "study_goal": "The researchers sought to examine how changes in food security relate to changes in dietary factors, including fruit juice consumption frequency.", "results_summary": "The abstract does not provide specific results regarding fruit juice's effects, only mentioning that participants self-reported juice consumption frequency as part of dietary factors.", "population_specificity": "Adult participants in a clinical-community emergency food assistance program in New York City.", "effective_dosage": "Not available", "study_duration": "Six months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:53:21.607342+00:00"}
{"study_id": 65810, "supplement_id": 1145, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 85, "study_goal": "The researchers aimed to synthesize evidence on the association between 100% fruit juice consumption and body weight changes in children and adults.", "results_summary": "In children, each additional daily serving of 100% fruit juice was associated with a small BMI increase. In adults, studies unadjusted for energy intake showed weight gain, while energy-adjusted studies did not. RCTs in adults found no significant weight change.", "population_specificity": "Children (median age 8 years) and adults (median age 48 years for cohorts, 42 years for RCTs).", "effective_dosage": "1 serving per day (specific volume not detailed).", "study_duration": "Cohort studies: \u22656 months; RCTs: \u22652 weeks.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:53:23.801918+00:00"}
{"study_id": 65812, "supplement_id": 1145, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 85, "study_goal": "The researchers aimed to study associations between sugar-sweetened beverages (excluding fruit juice) and artificially sweetened beverages with liver cancer incidence and chronic liver disease mortality.", "results_summary": "The study found no significant association between artificially sweetened beverage intake and liver cancer incidence or chronic liver disease mortality. Fruit juice was explicitly excluded from the analysis.", "population_specificity": "Postmenopausal women aged 50-79 years enrolled in the Women's Health Initiative.", "effective_dosage": "Not specified for fruit juice (excluded from analysis).", "study_duration": "Median follow-up of 20.9 years.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:53:27.500219+00:00"}
{"study_id": 65815, "supplement_id": 1145, "safety_score": "Not Assessed", "efficacy_score": 30, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the effect of the \"FOODcamp\" intervention on dietary habits, including sugar-sweetened beverages (potentially fruit juice), among 6th-7th graders.", "results_summary": "The study found no statistically significant effects of the intervention on the intake of food groups eaten regularly, including vegetables/fruit/juice combined.", "population_specificity": "6th-7th graders (aged 11-13 years) from nine schools.", "effective_dosage": "Not specified", "study_duration": "School year 2019-2020 (exact duration not specified)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:53:27.991290+00:00"}
{"study_id": 65816, "supplement_id": 1145, "safety_score": "Not Assessed", "efficacy_score": 30, "quality_score": 75, "study_goal": "The researchers aimed to investigate the association between fruit juice consumption and the risk of gestational diabetes mellitus (GDM).", "results_summary": "The study found that increased fruit juice consumption was not associated with a reduction in the risk of GDM (RR = 0.97, 95% CI = 0.91-1.04). No significant protective effect was observed.", "population_specificity": "Pregnant women at risk of or diagnosed with gestational diabetes mellitus (GDM).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:53:28.805147+00:00"}
{"study_id": 65818, "supplement_id": 1145, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to determine if a low-free sugar diet (including reduced fruit juice consumption) could prevent liver fat accumulation and NAFLD in high-risk Hispanic children.", "results_summary": "The study protocol describes a dietary intervention targeting free sugars (including those in fruit juice) to prevent NAFLD, but results are not yet available as the study is ongoing.", "population_specificity": "Hispanic children aged 6-9 years with BMI \u226550th percentile and no prior NAFLD diagnosis.", "effective_dosage": "Not specified", "study_duration": "12-month intervention with follow-up assessments up to 24 months.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:53:29.170109+00:00"}
{"study_id": 65817, "supplement_id": 1145, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to determine if introducing 100% fruit juice before 6 months of age is associated with higher juice and sugar-sweetened beverage intake at 24 months, and whether sociodemographic factors influence this relationship.", "results_summary": "Early introduction of 100% fruit juice (before 6 months) was associated with a 43% increase in juice intake at 24 months, exceeding recommended levels. The study found prevalent excessive juice intake in the cohort, suggesting early introduction may lead to higher consumption later.", "population_specificity": "Infants (aged 2-24 months) from a diverse cohort (43% Hispanic, 39% non-Hispanic Black) in the control arm of the Greenlight trial.", "effective_dosage": "Not specified (intake measured in ounces: 8.2 oz vs. 5.3 oz at 24 months for early vs. late introduction groups).", "study_duration": "Follow-up from 2 to 24 months of age.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:53:31.947314+00:00"}
{"study_id": 65822, "supplement_id": 1145, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 80, "study_goal": "The researchers aimed to investigate the effects of orange and apple pomaces (removed during fruit juice production) on gastrointestinal outcomes in healthy adults.", "results_summary": "The abstract does not provide specific results regarding the effects of fruit juice, but it suggests that the study examined how pomace influences GI health, including laxation, microbiota shifts, and bile acid metabolism.", "population_specificity": "Healthy, free-living adults.", "effective_dosage": "Not specified in the abstract.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:53:32.092156+00:00"}
{"study_id": 65823, "supplement_id": 1145, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to test the effects of an intervention designed to reduce excess fruit juice consumption among low-income parents and their infants/toddlers.", "results_summary": "The intervention significantly reduced 100% fruit juice consumption in both parents and children compared to the control group, with parents reducing intake by 3.6 fl oz/d and children by 0.73 fl oz/d. No significant differences were found between groups for SSB and water consumption changes.", "population_specificity": "Low-income, predominantly Hispanic parents and their infants/toddlers participating in Early Head Start home-visiting programs.", "effective_dosage": "Not specified", "study_duration": "12 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:53:36.027630+00:00"}
{"study_id": 65828, "supplement_id": 1145, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to determine the effect of motivational video stimulation and nutrition (including juice) on the non-stress test (NST) in pregnant women.", "results_summary": "The abstract does not provide specific results regarding the effects of fruit juice.", "population_specificity": "360 pregnant women, divided into three groups (two experimental and one control).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:53:36.491284+00:00"}
{"study_id": 65827, "supplement_id": 1145, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the relationship between 100% fruit juice intake and obesity in children and adolescents, identifying major risk factors influencing this relationship.", "results_summary": "The study found no overall relationship between 100% fruit juice intake and obesity measures in most children, though a minor positive association was noted in some overweight or very young children. Methodological limitations and gaps in literature, particularly regarding randomized clinical trials and racially diverse populations, were highlighted.", "population_specificity": "Children and adolescents \u2264 19 years old", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:53:37.126893+00:00"}
{"study_id": 65811, "supplement_id": 1145, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to compare gastric emptying times of fruit juices (mango and blackcurrant) and oat drinks with varying caloric and nutrient content.", "results_summary": "The study found that higher-calorie fruit juice (mango) had slower gastric emptying times compared to lower-calorie fruit juice (blackcurrant). Oat drinks with higher fat content also delayed gastric emptying more than lower-fat versions.", "population_specificity": "Healthy adult volunteers (8 females and 8 males).", "effective_dosage": "Single servings of mango juice (310 kcal) and blackcurrant juice (175 kcal).", "study_duration": "4-hour gastric ultrasound assessment post-ingestion.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:53:37.784259+00:00"}
{"study_id": 65826, "supplement_id": 1145, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the effectiveness of a homemade milk- and fruit-juice-based beverage as part of a hybrid intervention for weight loss and cardiometabolic risk improvement in high-risk adults.", "results_summary": "The fruit-juice-based beverage, combined with other interventions, contributed to significant weight loss (2.9 kg in the LD group) and improved cardiometabolic risk factors, though the difference between groups was not statistically significant. The study demonstrated feasibility and effectiveness in a humanitarian crisis setting.", "population_specificity": "Overweight/obese adults at high risk of type 2 diabetes mellitus in Venezuela during the COVID-19 pandemic.", "effective_dosage": "Not specified", "study_duration": "2 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:53:38.223138+00:00"}
{"study_id": 65829, "supplement_id": 1145, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to determine how dietary patterns, including fruit juice consumption, influenced glycaemic control in children with T1DM following carbohydrate-restricted diets.", "results_summary": "Patients who ranked fruit juice as their most common drink choice achieved better glycaemic control with a 30% carbohydrate diet, while those with different dietary patterns saw negative impacts. The 50% carbohydrate diet was safe for all patients regarding glycaemic control.", "population_specificity": "30 children (16 boys, 14 girls) aged 10-17 years with type 1 diabetes mellitus (T1DM).", "effective_dosage": "Not specified", "study_duration": "Two consecutive 3-day nutritional plans", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:53:40.992302+00:00"}
{"study_id": 65831, "supplement_id": 1145, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to determine whether vitamin D supplementation via fruit juice could improve microvascular reactivity in obese adolescents during a lifestyle program.", "results_summary": "Vitamin D-supplemented fruit juice improved endothelium-dependent microvascular reactivity in obese adolescents, reaching levels comparable to normal-weight controls, but did not affect macrovascular function. HOMA-IR and CRP decreased in all obese adolescents, with greater increases in 25(OH)D levels in the supplemented group.", "population_specificity": "Obese adolescents (n=26) and normal-weight adolescents (n=23, controls).", "effective_dosage": "4000 IU/d of vitamin D (in supplemented group).", "study_duration": "3 months.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:53:41.278673+00:00"}
{"study_id": 65820, "supplement_id": 1145, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 80, "study_goal": "The researchers aimed to determine whether a bundled intervention (including meal delivery and cooking resources) improved dietary quality, including fruit and fruit juice intake, in preschool-aged children.", "results_summary": "The intervention increased typical daily dietary intake of fruit and fruit juice in the MOW cohort (1.50 to 1.66 cup equivalents), but no significant changes were observed in the COM cohort or overall meal frequency or BMIz.", "population_specificity": "Preschool-aged children (mean age 4.4 years; 47% male; 55% White, 18% Black, 27% Hispanic or other race/ethnicity; 25% overweight or obese).", "effective_dosage": "Not specified", "study_duration": "12 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:53:41.556516+00:00"}
{"study_id": 65832, "supplement_id": 1145, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to investigate associations between food parenting practices (including home availability of 100% fruit juice) and children's dietary intake and compliance with recommendations.", "results_summary": "The study found strong cross-sectional associations between home availability of 100% fruit juice and corresponding intake, with significant beta values (\u03b2 = 0.492 in girls and \u03b2 = 0.506 in boys).", "population_specificity": "6- to 11-year-old European children (2967 parent-child dyads, 50.4% girls, 93.5% mothers).", "effective_dosage": "Not specified", "study_duration": "Two-year follow-up", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:53:44.699333+00:00"}
{"study_id": 65833, "supplement_id": 1145, "safety_score": "30", "efficacy_score": 40, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the metabolic effects of fructose consumption, particularly from sugary dietary items like fruit juice, and its association with weight gain and metabolic syndrome.", "results_summary": "The study found that excessive fructose consumption, including from fruit juice, leads to weight gain, elevated triglyceride levels, and liver fat accumulation when associated with a positive energy balance. No significant effects were observed under isocaloric conditions.", "population_specificity": "Adults and children, with a focus on toddlers under age two.", "effective_dosage": "Fructose dose + 25-40% of the total caloric requirement.", "study_duration": "Observation periods of one to ten weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:53:44.973134+00:00"}
{"study_id": 65837, "supplement_id": 1145, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to determine the effects of fruit-based anthocyanins on microvascular function, blood pressure, and inflammatory biomarkers in older adults with mild cognitive impairment (MCI).", "results_summary": "A high dose of fruit-based anthocyanins reduced serum TNF-\u03b1 levels but did not affect other inflammatory biomarkers, microvascular function, or blood pressure parameters.", "population_specificity": "Older adults (mean age 75.3 years) with mild cognitive impairment (MCI).", "effective_dosage": "High dose (specific amount not stated in abstract).", "study_duration": "8 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:53:46.204651+00:00"}
{"study_id": 65838, "supplement_id": 1145, "safety_score": "90", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to compare the effectiveness of fruit juice against glucose and sugar fondant candies in correcting hypoglycemia during prolonged aerobic exercise in children with type 1 diabetes.", "results_summary": "The study found no significant differences among fruit juice, glucose, and sugar fondant in terms of time spent in hypoglycemia, rise in blood glucose levels, or number of hypoglycemic events after correction, suggesting all three were equally effective.", "population_specificity": "21 children with type 1 diabetes, aged 12-16 years.", "effective_dosage": "0.3g per Kg of body weight.", "study_duration": "5 days (trekking camp).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:53:46.951008+00:00"}
{"study_id": 65834, "supplement_id": 1145, "safety_score": "Not Assessed", "efficacy_score": 30, "quality_score": 75, "study_goal": "The researchers aimed to investigate the effects of a multi-ingredient fruit juice-based supplement on body composition, physical function, and metabolic health in older adults with low skeletal muscle mass.", "results_summary": "The study found no change in lean body mass in either group, but fat mass increased in the supplement group by 1.41 kg after 6 months. Other outcomes were not detailed in the abstract.", "population_specificity": "Community-dwelling older adults (age 74.9 \u00b1 3.6 years; 18 males, 19 females) with low skeletal muscle mass.", "effective_dosage": "200 mL daily of a juice-based emulsion containing LC n-3 PUFA (3000 mg), whey protein isolate (8 g), vitamin D3 (400 IU), and resveratrol (150 mg).", "study_duration": "6 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:53:47.086741+00:00"}
{"study_id": 65839, "supplement_id": 1145, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to review the evolutionary history of chloroplasts and their applications, including the use of enzymes derived from chloroplast genomes in processing fruit juice.", "results_summary": "The abstract mentions that commercial products developed from chloroplast genomes include enzymes used in processing fruit juice, but it does not provide specific results on the efficacy or safety of these enzymes in fruit juice.", "population_specificity": "Not specified", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:53:48.174976+00:00"}
{"study_id": 65841, "supplement_id": 1145, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 70, "study_goal": "The researchers aimed to assess the acceptability and effectiveness of a prolonged-release protein substitute mixed with food or fruit juice in children with PKU.", "results_summary": "Seven of 13 subjects successfully took the prescribed dose over 7 days, with most mixing the substitute with food or fruit juice. Reduced blood phenylalanine levels were observed, but adherence remained a challenge for some.", "population_specificity": "Children with phenylketonuria (PKU).", "effective_dosage": "Replaced \u22651 dose per day of the usual protein substitute.", "study_duration": "7 days.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:53:49.945622+00:00"}
